Wilensky RL, Tanguay JF, Ito S, Bartorelli AL, Moses J, Williams DO, Bailey SR, Martin J, Bucher TA, Gallant P, Greenberg A, Popma JJ, Weissman NJ, Mintz GS, Kaplan AV, Leon MB
Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia. Am Heart J. 2000 Jun; 139(6):1061-70.
Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia.
Dauerman HL, Prpic R, Andreou C, Vu MA, Popma JJ
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Angiographic and clinical outcomes after rescue coronary stenting. Catheter Cardiovasc Interv. 2000 Jul; 50(3):269-75.
Angiographic and clinical outcomes after rescue coronary stenting.
Little SH, Popma JJ, Kleiman NS, Deeb GM, Gleason TG, Yakubov SJ, Checuti S, O'Hair D, Bajwa T, Mumtaz M, Maini B, Hartman A, Katz S, Robinson N, Petrossian G, Heiser J, Merhi W, Moore BJ, Li S, Adams DH, Reardon MJ
The Journal of thoracic and cardiovascular surgery
Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery. J Thorac Cardiovasc Surg. 2018 05; 155(5):1991-1999.
Transcatheter aortic valve replacement in patients with severe mitral or tricuspid regurgitation at extreme risk for surgery.
Bruce CJ, Kuntz RE, Popma JJ, Pieper KS, Topol EJ, Holmes DR
Journal of the American College of Cardiology
Application of a continuous regression model of restenosis to saphenous vein grafts after successful percutaneous transluminal coronary angioplasty or directional coronary atherectomy. J Am Coll Cardiol. 2000 Mar 01; 35(3):619-23.
Application of a continuous regression model of restenosis to saphenous vein grafts after successful percutaneous transluminal coronary angioplasty or directional coronary atherectomy.
Saucedo JF, Kennard ED, Popma JJ, Talley D, Lansky A, Leon MB, Baim DS
Importance of lesion length on new device angioplasty of native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. Catheter Cardiovasc Interv. 2000 May; 50(1):19-25.
Importance of lesion length on new device angioplasty of native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions.
Popma JJ, Cox N, Wahr D, Hermann H, Simon DI, Rogers CD, Kramer P, Shear W, Shunk K, Yeung A, Prpic R, Adelman D, Kereiakes D
A quantitative assessment of regional changes in lumen diameter after photodynamic therapy with metoxefin in patients undergoing stent implantation. J Am Coll Cardiol. 2002; 39(5):26A.
A quantitative assessment of regional changes in lumen diameter after photodynamic therapy with metoxefin in patients undergoing stent implantation
Popma JJ, Ellis SG, Cox D, Hermiller J, O'Shaughnessy C, Mann JT, Russell ME, Stone G
Late Quantitative Angiographic Results Following Treatment With a Polymer-Based Paclitaxel-Eluting Stent Compared With a Bare Metal Stent in Patients With De Novo Coronary Disease: The TAXUS-IV Angiographic Results. J Am Coll Cardiol. 2004; in press.
Late Quantitative Angiographic Results Following Treatment With a Polymer-Based Paclitaxel-Eluting Stent Compared With a Bare Metal Stent in Patients With De Novo Coronary Disease: The TAXUS-IV Angiographic Results
Hong MK, Wong SC, Mintz GS, Farb A, Kent KM, Pichard AD, Satler LF, Popma JJ, Sidawy A, Virmani R
A modified directional atherectomy catheter for resection of calcified atherosclerotic plaques. Coron Artery Dis. 1995 Apr; 6(4):335-9.
A modified directional atherectomy catheter for resection of calcified atherosclerotic plaques.
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 Jan 15; 350(3):221-31.
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Mauri L, O'Malley AJ, Cutlip DE, Ho KK, Popma JJ, Chauhan MS, Baim DS, Cohen DJ, Kuntz RE
Effects of stent length and lesion length on coronary restenosis. Am J Cardiol. 2004 Jun 01; 93(11):1340-6, A5.
Effects of stent length and lesion length on coronary restenosis.
Hoffmann R, Langenberg R, Radke P, Franke A, Blindt R, Ortlepp J, Popma JJ, Weber C, Hanrath P
Evaluation of a high-dose dexamethasone-eluting stent. Am J Cardiol. 2004 Jul 15; 94(2):193-5.
Evaluation of a high-dose dexamethasone-eluting stent.
Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O'Neill W, Lasala J, Reisman M, Sharma SK, Kuntz RE, Bonan R
Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J. 2005 Apr; 149(4):689-94.
Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.
Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Mehran R, Na Y, Turco M, Caputo R, Popma JJ, Cutlip DE, Russell ME, Cohen DJ
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol. 2006 Jul 04; 48(1):32-6.
Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
Leon MB, Moses JW, Weisz G, Teirstein PS, Fitzgerald P, Holmes DR, Popma JJ
The frequency and consequences of angiographic aneurysms after sirolimus-eluting stents: Results from SIRIUS. J Am Coll Cardiol. 2003; 41(6):13A.
The frequency and consequences of angiographic aneurysms after sirolimus-eluting stents: Results from SIRIUS
In: Heart Disease: A Textbook of Cardiovascular Medicine (7th Edition).
Coronary Angiography and Intravascular Ultrasonography. In: Heart Disease: A Textbook of Cardiovascular Medicine (7th Edition). 2004.
Coronary Angiography and Intravascular Ultrasonography
New device angioplasty: the impact on restenosis. Coron Artery Dis. 1993 Mar; 4(3):243-53.
New device angioplasty: the impact on restenosis.
Henson KD, Popma JJ, Leon MB, Kent KM, Satler LF, Mintz GS, Keller MB, Deible R, Pichard AD
Comparison of results of rotational coronary atherectomy in three age groups (< 70, 70 to 79 and > or = 80 years). Am J Cardiol. 1993 Apr 01; 71(10):862-4.
Comparison of results of rotational coronary atherectomy in three age groups (< 70, 70 to 79 and > or = 80 years).
Mintz GS, Popma JJ, Pichard AD, Kent KM, Salter LF, Chuang YC, Griffin J, Leon MB
Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol. 1996 Jun; 27(7):1678-87.
Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization.
Hoffmann R, Mintz GS, Mehran R, Pichard AD, Kent KM, Satler LF, Popma JJ, Wu H, Leon MB
Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents. J Am Coll Cardiol. 1998 Jan; 31(1):43-9.
Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents.
Kornowski R, Klutstein M, Satler LF, Pichard AD, Kent KM, Abizaid A, Mintz GS, Hong MK, Popma JJ, Mehran R, Leon MB
Impact of stents on clinical outcomes in percutaneous left main coronary artery revascularization. Am J Cardiol. 1998 Jul 01; 82(1):32-7.
Impact of stents on clinical outcomes in percutaneous left main coronary artery revascularization.
Heparin dosing in patients undergoing coronary intervention. Am J Cardiol. 1998 Oct 22; 82(8B):19P-24P.
Heparin dosing in patients undergoing coronary intervention.
Okada K, Honda Y, Kitahara H, Otagiri K, Tanaka S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T
Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial. JACC Cardiovasc Interv. 2018 04 09; 11(7):648-661.
Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial.
Popma JJ, Ohman EM, Weitz J, Lincoff AM, Harrington RA, Berger P
Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest. 2001 Jan; 119(1 Suppl):321S-336S.
Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
Okura H, Morino Y, Oshima A, Hayase M, Ward MR, Popma JJ, Kuntz RE, Bonneau HN, Yock PG, Fitzgerald PJ
Preintervention arterial remodeling affects clinical outcome following stenting: an intravascular ultrasound study. J Am Coll Cardiol. 2001 Mar 15; 37(4):1031-5.
Preintervention arterial remodeling affects clinical outcome following stenting: an intravascular ultrasound study.
Popma JJ, Lansky AJ, Mintz GS, Hong MK, Brahimi A, Burwell N, Leon MB
Antithrombotic therapy after stent deployment. J Invasive Cardiol. 1996; 8(SupplB):34B-42B.
Antithrombotic therapy after stent deployment
Garrand TJ, Mintz GS, Popma JJ, Lewis SA, Vaughn NA, Leon MB
Intravascular ultrasound diagnosis of a coronary artery pseudoaneurysm following percutaneous transluminal coronary angioplasty. Am Heart J. 1993 Mar; 125(3):880-2.
Intravascular ultrasound diagnosis of a coronary artery pseudoaneurysm following percutaneous transluminal coronary angioplasty.
Bedotto JB, Eichhorn EJ, Popma JJ, Dehmer GJ
Effects of intravenous isradipine on left ventricular performance during rapid atrial pacing in coronary artery disease. Am J Cardiol. 1990 Jan 15; 65(3):189-94.
Effects of intravenous isradipine on left ventricular performance during rapid atrial pacing in coronary artery disease.
Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation. 2006 Dec 19; 114(25):2850-70.
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).
van den Berg EK, Popma JJ, Dehmer GJ, Snow FR, Lewis SA, Vetrovec GW, Nixon JV
Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation. 1990 Apr; 81(4):1210-6.
Reversible segmental left ventricular dysfunction after coronary angioplasty.
Han RO, Schwartz RS, Kobayashi Y, Wilson SH, Mann JT, Sketch MH, Safian RD, Lansky A, Popma J, Fitzgerald PJ, Palacios IF, Chazin-Caldie M, Goldberg S
Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. Am J Cardiol. 2001 Aug 01; 88(3):253-9.
Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis.
Kwok OH, Prpic R, Gaspar J, Mathey DG, Escobar A, Goldar-Najafi A, Reifart N, Ischinger TA, Popma JJ
Angiographic outcome after intracoronary X-Sizer helical atherectomy and thrombectomy: first use in humans. Catheter Cardiovasc Interv. 2002 Feb; 55(2):133-9.
Angiographic outcome after intracoronary X-Sizer helical atherectomy and thrombectomy: first use in humans.
Faridi KF, Popma JJ, Strom JB, Shen C, Choi E, Yeh RW
Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval. Am J Cardiol. 2018 06 01; 121(11):1365-1372.
Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval.
Tiroch K, Cannon L, Reisman M, Caputo R, Caulfield T, Heuser R, Braden G, Low R, Stone G, Almonacid A, Popma JJ
High-frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions. Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):771-80.
High-frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions.
Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv. 2009 Dec; 2(12):1269-75.
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Schampaert E, Cohen EA, Schlüter M, Reeves F, Traboulsi M, Title LM, Kuntz RE, Popma JJ
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004 Mar 17; 43(6):1110-5.
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).
Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehra M, Popma JJ, Donohoe D, Firth B, Keim E, Snead D
Journal of vascular and interventional radiology : JVIR
The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol. 2004 Sep; 15(9):911-8.
The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results.
Holmes DR, Coolong A, O'Shaughnessy C, Chauhan M, Van Langenhove G, Hall P, Vermeersch P, Verlee P, Popma JJ, Cutlip D, Kuntz RE
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial. EuroIntervention. 2006 Aug; 2(2):161-8.
Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial.
Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Weissman NJ, Koglin J, Russell ME
Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. EuroIntervention. 2007 Aug; 3(2):213-21.
Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents.
Rogers T, Waksman R, Harrison JK, Deeb GM, Zhang AQ, Hermiller JB, Popma JJ, Reardon MJ
Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis. Am J Cardiol. 2018 06 01; 121(11):1358-1364.
Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis.
Myla S, Bacharach JM, Ansel GM, Dippel EJ, McCormick DJ, Popma JJ
Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results. Catheter Cardiovasc Interv. 2010 May 01; 75(6):817-22.
Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results.
Dehmer GJ, Douglas JS, Abizaid A, Berg JW, Day J, Hall R, Leon MB, Hijazi ZM, Marchlinski F, Park SJ, Popma JJ
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future. J Am Coll Cardiol. 2010 Oct 05; 56(15):1267-82.
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future.
Textbook of Coronary Stenting. Leon MB, Stone GW (Editors)
Pharmacologic Approaches to Restenosis. Textbook of Coronary Stenting. Leon MB, Stone GW (Editors). 2005.
Giugliano G, Prpic R, Cutlip DE, Popma JJ, Ho KL, Mauri L, Kaya U, Wahr D, George B, Baim DS, Kuntz RE
Does the beneficial effect of distal protection in saphenous vein graft angioplasty vary with lesion length? A SAFER (Saphenous Vein Graft Angioplasty Free of Emboli Randomized) Substudy. J Am Coll Cardiol. 2002; 39(5):8A.
Does the beneficial effect of distal protection in saphenous vein graft angioplasty vary with lesion length? A SAFER (Saphenous Vein Graft Angioplasty Free of Emboli Randomized) Substudy
After the acute MI: How to improve prognosis. J Crit Illness. 1988; 3:89-105.
After the acute MI: How to improve prognosis
Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis. Am J Cardiol 2001 Aug 1;88(3):253-9. 2001; 88(3):253-9.
Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004; 109(19):2273-8.
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy
Detre KM, Baim D, Buchbinder M, Desvigne-Nickens P, Fishman NW, Hinohara T, Kennard ED, Litvack F, Popma J, Robertson T
Baseline characteristics and therapeutic goals in the New Approaches to Coronary Intervention (NACI) registry. Coron Artery Dis. 1993 Nov; 4(11):1013-22.
Baseline characteristics and therapeutic goals in the New Approaches to Coronary Intervention (NACI) registry.
Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Buellesfeld L, Koglin J, Russell ME
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur Heart J. 2007 Nov; 28(21):2578-82.
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions.
Vetrovec GW, Anderson M, Schreiber T, Popma J, Lombardi W, Maini B, Moller JE, Schäfer A, Dixon SR, Hall S, Ohman EM, Mindrescu C, Moses J, O'Neill W
The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. Am Heart J. 2018 05; 199:115-121.
The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.
Factors influencing restenosis after coronary angioplasty. Am J Med. 1990 Jan; 88(1N):16N-24N.
Factors influencing restenosis after coronary angioplasty.
Novack V, Battaglia L, Popma JJ, Cutlip DE
In-hospital and nine-month outcomes among patients with coronary lesions involving a side branch and treated with bare metal stents. Catheter Cardiovasc Interv. 2010 Dec 01; 76(7):951-7.
In-hospital and nine-month outcomes among patients with coronary lesions involving a side branch and treated with bare metal stents.
Cutlip DE, Chauhan MS, Baim DS, Ho KK, Popma JJ, Carrozza JP, Cohen DJ, Kuntz RE
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 2002 Dec 18; 40(12):2082-9.
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1988 Dec 01; 62(17):1298-9.
Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty.
Wong SC, Hong MK, Ellis SG, Buchbinder M, Reisman M, DeLago A, Kellett M, Popma JJ, Russell ME, Mehran R, Moses JW, Stone GW
Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study). Am J Cardiol. 2005 May 01; 95(9):1043-8.
Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).
Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, Mügge A, Di Pede F, Füllgraf D, Aengevaeren W, Spedicato L, Popma JJ
Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation. 2005 Apr 26; 111(16):2107-11.
Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement.
Laskey WK, Heuser RR, Suntharaligam M, Bass TA, Silber S, Rutherford BD, Wilmer C, Berke AD, Snell J, Popma JJ, Kuntz RE
Effects of 90Sr-90Y beta radiation on diabetic patients with in-stent restenosis. Circulation. 2000; 102(18):II-668.
Effects of 90Sr-90Y beta radiation on diabetic patients with in-stent restenosis
Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol. 1992 Apr; 19(5):926-35.
Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile.
Kuntz RE, Baim DS, Cohen DJ, Popma JJ, Carrozza JP, Sharma S, McCormick DJ, Schmidt DA, Lansky AJ, Ho KK, Dandreo KJ, Setum CM, Ramee SR
A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol. 2002 Feb 01; 89(3):326-30.
A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]).
Popma JJ;, Lansky AJ, Purkayastha DD, Hall LR, Bonan R
Angiographic and clinical outcome after cutting balloon angioplasty. J Invasive Cardiol. 1996; 8(Suppl A):12A-19A.
Angiographic and clinical outcome after cutting balloon angioplasty
Predictors of In-Stent Restenosis. Textbook of Coronary Stenting. Leon MB, Stone GW (Editors). 2005.
Coronary Stenting in Patient with Unstable Angina. Textbook of Coronary Stenting. Leon MB, Stone GW (Editors). 2005.
Coronary Stenting in Patient with Unstable Angina
Silva JA, Ramee SR, Cohen DJ, Carrozza JP, Popma JJ, Lansky AA, Dandreo K, Baim DS;
Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. Am Heart J 2001 Mar;141(3):353-9. 2001; 141(3):353-9.
Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter
Painter JA, Mintz GS, Wong SC, Popma JJ, Pichard AD, Kent KM, Satler LF, Leon MB
Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol. 1995 Feb 15; 75(5):398-400.
Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil.
Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol. 1994 Dec 15; 74(12):1278-80.
Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings.
Goldfarb M, Lauck S, Webb JG, Asgar AW, Perrault LP, Piazza N, Martucci G, Lachapelle K, Noiseux N, Kim DH, Popma JJ, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Morais JA, Morin JF, Rudski LG, Afilalo J
Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement. Circulation. 2018 11 13; 138(20):2202-2211.
Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement.
Popma JJ, Dick RJ, Haudenschild CC, Topol EJ, Ellis SG
Atherectomy of right coronary ostial stenoses: initial and long-term results, technical features and histologic findings. Am J Cardiol. 1991 Feb 15; 67(5):431-3.
Atherectomy of right coronary ostial stenoses: initial and long-term results, technical features and histologic findings.
Halkin A, Masud AZ, Rogers C, Hermiller J, Feldman R, Hall P, Haber RH, Cambier PA, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA, Mehran R, Stone GW
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. Am Heart J. 2006 Apr; 151(4):915.e1-7.
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
Moussa ID, Moses JW, Kuntz RE, Holmes DR, Popma JJ, Teirstein PS, Wong SC, Leon MB
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). Am J Cardiol. 2006 Jun 01; 97(11):1582-4.
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
Heart Disease: A Textbook of Cardiovascular Medicine (6th Edition). Braunwald E, Zipes DP, Libby P (Editors)
Percutaneous Coronary and Valvular Intervention. Heart Disease: A Textbook of Cardiovascular Medicine (6th Edition). Braunwald E, Zipes DP, Libby P (Editors). 2001; 1364-1405.
Percutaneous Coronary and Valvular Intervention
Ellis SG, Colombo A, Grube E, Popma J, Koglin J, Dawkins KD, Stone GW
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol. 2007 Mar 13; 49(10):1043-51.
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
Lincoff AM, Popma JJ, Bates ER, Deeb GM, Bolling SF, Meagher JS, Kelly AM, Wampler RK, Nicklas JM
Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device. Am Heart J. 1990 Oct; 120(4):970-2.
Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device.
After the acute MI: Assessing the patient's risk. J Crit Illness. 1988; 3:11-32.
After the acute MI: Assessing the patient's risk
Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology. JACC Cardiovasc Interv. 2009 Sep; 2(9):894-6.
Reduced reimbursement for cardiovascular services by the Centers for Medicare and Medicaid Services: perspective from interventional cardiology.
Serruys PW, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra PW, Kappetein AP, Onuma Y, Søndergaard L, van Mieghem N
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. EuroIntervention. 2018 Oct 20; 14(8):877-883.
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial.
Abizaid A, Popma JJ, Tanajura LF, Hattori K, Solberg B, Larracas C, Feres F, Costa Jde R, Schwartz LB
Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial. Catheter Cardiovasc Interv. 2007 Dec 01; 70(7):914-9.
Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: the TriMaxx trial.
Morino Y, Honda Y, Takagi A, Limpijanit T, Waksman R, Bonan R, Popma JJ, Lansky AJ, Bass T, Yock PG, Fitzpatrick PJ
Relationship between vessel size and late lumen loss following intracoronary beta- and gamma-radiation therapy. J Am Coll Cardiol. 2001; 37(2):57A.
Relationship between vessel size and late lumen loss following intracoronary beta- and gamma-radiation therapy
Resnic FS, Olmo-Machado L, Blake G, Selwyn A, Simon DI, Popma JJ
Observed protective effect of glycoprotein IIb/IIIa antagonists against in-hospital death stratified by patient risk. J Am Coll Cardiol. 2000; 35(2):91A.
Observed protective effect of glycoprotein IIb/IIIa antagonists against in-hospital death stratified by patient risk
Five Trials That Changed Our Management of Non-ST-Elevation MI and Unstable Angina, in Academy of TCT Proceedings. A bimonthly publication of the Cardiovascular Research Foundation, New York, NY
Five Trials That Changed Our Management of Non-ST-Elevation MI and Unstable Angina, in Academy of TCT Proceedings. A bimonthly publication of the Cardiovascular Research Foundation, New York, NY. 2004.
CathSAP-II Nissen SE (Editor), Popma JJ, Kern MJ (Co-Editor)
Stent Indications. CathSAP-II Nissen SE (Editor), Popma JJ, Kern MJ (Co-Editor). 2001.
Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Hong MK, Leon MB
Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty. J Invasive Cardiol. 1996; 8(1):1-14.
Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty
Shavelle DM, Banerjee S, Maini B, Schreiber TL, Kapasi N, O'Neill WW, Popma J, Matthews RV
Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry). Am J Cardiol. 2018 09 15; 122(6):966-972.
Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
Popma JJ, Ho K, Prpic R, Giri S, Rao R, Cutlip DE, Firer L, Lanina A, Badareldin M, Kuntz RE.
Predictors of early complications and "optimal" stent results after native vessel coronary stenting. Is the ACC/AHA lesion system useful in predicting outcomes. J Am Coll Cardiol. 2000; 35(2):29A.
Predictors of early complications and "optimal" stent results after native vessel coronary stenting. Is the ACC/AHA lesion system useful in predicting outcomes
Painter JA, Mintz GS, Wong SC, Popma JJ, Pichard AD, Kent KM, Satler LF, Hong MK, Leon MB
Intravascular ultrasound assessment of biliary stent implantation in saphenous vein grafts. Am J Cardiol. 1995 Apr 01; 75(10):731-4.
Intravascular ultrasound assessment of biliary stent implantation in saphenous vein grafts.
Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Popma JJ, Gao R, Stone GW
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial. EuroIntervention. 2018 Aug 03; 14(5):e554-e561.
Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial.
Silva JA, Ramee SR, Cohen D, Carrozza JP, Popma JJ, Dandreo K, Lansky AL, Baim D, George DS, McCormick DJ, Setum CM, Kuntz RE
Rheolytic Thrombectomy for the Treatment of Acute Myocardial Infarction in Patients With Angiographic Large Thrombus Burden: One-Year Results of the VeGAS 2 Acute Myocardial Infarction Registry. J Am Coll Cardiol. 2004; in press.
Rheolytic Thrombectomy for the Treatment of Acute Myocardial Infarction in Patients With Angiographic Large Thrombus Burden: One-Year Results of the VeGAS 2 Acute Myocardial Infarction Registry
Popma JJ, Mintz GS, Satler LF, Pichard AD, Kent KM, Chuang YC, Matar F, Bucher TA, Merritt AJ, Leon MB
Clinical and angiographic outcome after directional coronary atherectomy. A qualitative and quantitative analysis using coronary arteriography and intravascular ultrasound. Am J Cardiol. 1993 Oct 18; 72(13):55E-64E.
Clinical and angiographic outcome after directional coronary atherectomy. A qualitative and quantitative analysis using coronary arteriography and intravascular ultrasound.
Ellis SG, Popma JJ, Buchbinder M, Franco I, Leon MB, Kent KM, Pichard AD, Satler LF, Topol EJ, Whitlow PL
Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation. 1994 Feb; 89(2):882-92.
Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty.
Hong MK, Wong SC, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Leon MB
Catheterization and cardiovascular diagnosis
Can coronary flow parameters after stent placement predict restenosis? Cathet Cardiovasc Diagn. 1995 Nov; 36(3):278-80.
Can coronary flow parameters after stent placement predict restenosis?
Weisz G, Leon MB, Holmes DR, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol. 2009 Apr 28; 53(17):1488-97.
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
Meredith IT, Worthley S, Whitbourn R, Walters D, Popma J, Cutlip D, Fitzgerald P
The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial. EuroIntervention. 2007 May; 3(1):50-3.
The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial.
Garg P, Charytan DM, Novack L, Cutlip DE, Popma JJ, Moses J, Leon MB, Schofer J, Breithardt G, Schampaert E, Mauri L
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). Am J Cardiol. 2010 Nov 15; 106(10):1436-42.
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials).
Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011 Jan; 32(2):205-17.
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
Shi S, Afilalo J, Lipsitz LA, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Grodstein F, Lux E, Kim DH
The journals of gerontology. Series A, Biological sciences and medical sciences
Frailty Phenotype and Deficit Accumulation Frailty Index in Predicting Recovery After Transcatheter and Surgical Aortic Valve Replacement. J Gerontol A Biol Sci Med Sci. 2019 07 12; 74(8):1249-1256.
Frailty Phenotype and Deficit Accumulation Frailty Index in Predicting Recovery After Transcatheter and Surgical Aortic Valve Replacement.
Ellis S, Popma JJ, Weissman N, Turco M, Caputo R, Bergin P, Greenberg J, Raizner A, Koglin J, Russell ME, Stone GE
Impact of Late Loss on Clinical, Angiographic and Intravascular Ultrasound Outcomes in the TAXUS IV Trial. J Am Coll Cardiol. 2004; in press.
Impact of Late Loss on Clinical, Angiographic and Intravascular Ultrasound Outcomes in the TAXUS IV Trial
Popma JJ, Cox D, Farhat N, Midei M, Schomig A, Hermiller J, Werner J, Sievers M, Fink S, Linnemeier T
Late angiographic and clinical findings after elective placement of the Penta stent: Results from the PENTA Stent Registry. J Am Coll Cardiol. 2002; 39(5):4A.
Late angiographic and clinical findings after elective placement of the Penta stent: Results from the PENTA Stent Registry
Nissen SE (Editor), Popma JJ (Co-Editor), Kern MJ (Co-Editor)
Cathsap II: Cardiac catheterization and Interventional Cardiology Self-Assessment
Cathsap II: Cardiac catheterization and Interventional Cardiology Self-Assessment. 2001.
Stone GW, Ellis SG, O'Shaughnessy C, Mann JT, Turco M, Raizner A, Cannon L, Kutcher M, Gurbel P, Wong SC, Russell ME, Popma JJ
Reduction in Late Loss and Restenosis in Patients With Small Vessels Treated With the Slow Rate-Release, Polymer-Based Paclitaxel-Eluting Stent: Results From TAXUS-IV. J Am Coll Cardiol. 2004; in press.
Reduction in Late Loss and Restenosis in Patients With Small Vessels Treated With the Slow Rate-Release, Polymer-Based Paclitaxel-Eluting Stent: Results From TAXUS-IV
Fischell TA, Mirza T, Haller T, Popma JJ
Potential Impact of Frame Bias Upon Quantitative Coronary Angiographic Outcomes in Coronary Stent Trials. J Am Coll Cardiol. 2004; in press.
Potential Impact of Frame Bias Upon Quantitative Coronary Angiographic Outcomes in Coronary Stent Trials
Grayburn PA, Oh JK, Reardon MJ, Popma JJ, Deeb GM, Boulware M, Huang J, Stoler RC
Effect of Baseline Aortic Regurgitation on Mortality in Patients Treated With Transcatheter or Surgical Aortic Valve Replacement (from the CoreValve US Pivotal Trial). Am J Cardiol. 2018 11 01; 122(9):1527-1535.
Effect of Baseline Aortic Regurgitation on Mortality in Patients Treated With Transcatheter or Surgical Aortic Valve Replacement (from the CoreValve US Pivotal Trial).
Kovach JA, Mintz GS, Pichard AD, Kent KM, Popma JJ, Satler LF, Leon MB
Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty. J Am Coll Cardiol. 1993 Oct; 22(4):1024-32.
Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty.
Popma JJ, De Cesare NB, Pinkerton CA, Kereiakes DJ, Whitlow P, King SB, Topol EJ, Holmes DR, Leon MB, Ellis SG
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy. Am J Cardiol. 1993 Mar 01; 71(7):552-7.
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomy.
Mintz GS, Kovach JA, Javier SP, Pichard AD, Kent KM, Popma JJ, Salter LF, Leon MB
Mechanisms of lumen enlargement after excimer laser coronary angioplasty. An intravascular ultrasound study. Circulation. 1995 Dec 15; 92(12):3408-14.
Mechanisms of lumen enlargement after excimer laser coronary angioplasty. An intravascular ultrasound study.
Cannon LA, Kereiakes DJ, Mann T, Popma JJ, Mooney MR, Mishkel GJ, Lee TC, Wilson BH, Stuckey TD, Orlow S, McGarry T, Ring ME, Kellett MA, Underwood P, Dawkins KD
A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. EuroIntervention. 2011 Mar; 6(8):920-7, 1-2.
A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.
Brott TG, Hobson RW, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 01; 363(1):11-23.
Stenting versus endarterectomy for treatment of carotid-artery stenosis.
Popma JJ, Cigarroa RG, Buja LM, Hillis LD
Diagnostic and prognostic utility of right-sided catheterization and endomyocardial biopsy in idiopathic dilated cardiomyopathy. Am J Cardiol. 1989 Apr 15; 63(13):955-8.
Diagnostic and prognostic utility of right-sided catheterization and endomyocardial biopsy in idiopathic dilated cardiomyopathy.
Rogers JH, Goldstein I, Kandzari DE, Köhler TS, Stinis CT, Wagner PJ, Popma JJ, Jaff MR, Rocha-Singh KJ
Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol. 2012 Dec 25; 60(25):2618-27.
Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors.
Moses JW, Leon MB, Popma JJ, Cohen SA, Kuntz RE
Direct Stenting Using the Sirolimus-Eluting Bx VELOCITY Stent: Procedural, Clinical, and Angiographic Outcomes Compared to a Predilatation Strategy. J Am Coll Cardiol. 2004; in press.
Direct Stenting Using the Sirolimus-Eluting Bx VELOCITY Stent: Procedural, Clinical, and Angiographic Outcomes Compared to a Predilatation Strategy
Prpic R, Lewandowski W, Sasseen B, Popma J
The Use of Medical Simulators as Part of a Comprehensive Interventional Cardiology Teaching Course. J Am Coll Cardiol. 2004; in press.
The Use of Medical Simulators as Part of a Comprehensive Interventional Cardiology Teaching Course
May DC, Popma JJ, Black WH, Schaefer S, Lee HR, Levine BD, Hillis LD
Induction and reversal of nitroglycerin tolerance in human coronary arteries in vivo. New Engl J Med. 1987; 327:805-809..
Induction and reversal of nitroglycerin tolerance in human coronary arteries in vivo
Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Müller-Hülsbeck S
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet. 2018 10 27; 392(10157):1541-1551.
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Cardiol. 2018 12 04; 72(22):2687-2696.
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.
Interventional Fellows Complications Course: A CD Compendium
Interventional Fellows Complications Course: A CD Compendium. 2004.
Care of the patient after coronary angioplasty: Evaluation and management. Ann Int Med. 1989; 110:547-559.
Care of the patient after coronary angioplasty: Evaluation and management
Mintz GS, Pichard AD, Popma JJ, Kent KM, Satler LF, Leon MB
Preliminary experience with adjunct directional coronary atherectomy after high-speed rotational atherectomy in the treatment of calcific coronary artery disease. Am J Cardiol. 1993 Apr 01; 71(10):799-804.
Preliminary experience with adjunct directional coronary atherectomy after high-speed rotational atherectomy in the treatment of calcific coronary artery disease.
Popma JJ, De Cesare NB, Ellis SG, Holmes DR, Pinkerton CA, Whitlow P, King SB, Ghazzal ZM, Topol EJ, Garratt KN
Clinical, angiographic and procedural correlates of quantitative coronary dimensions after directional coronary atherectomy. J Am Coll Cardiol. 1991 Nov 01; 18(5):1183-9.
Clinical, angiographic and procedural correlates of quantitative coronary dimensions after directional coronary atherectomy.
Sketch MH, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ
Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol. 2005 Jan 01; 95(1):8-12.
Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system.
Javier SP, Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Leon MB
Intravascular ultrasound assessment of the magnitude and mechanism of coronary artery and lumen tapering. Am J Cardiol. 1995 Jan 15; 75(2):177-80.
Intravascular ultrasound assessment of the magnitude and mechanism of coronary artery and lumen tapering.
Weisz G, Moses JW, Teirstein PS, Holmes DR, Raizner AE, Satler LF, Mishkel G, Wilensky RL, Wang P, Kuntz RE, Popma JJ, Leon MB
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). Am J Cardiol. 2007 Apr 15; 99(8):1044-50.
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Kereiakes DJ, Teirstein PS, Sarembock IJ, Holmes DR, Krucoff MW, O'Neill WW, Waksman R, Williams DO, Popma JJ, Buchbinder M, Mehran R, Meredith IT, Moses JW, Stone GW
The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 2007 Oct 16; 50(16):1598-603.
The truth and consequences of the COURAGE trial.
Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Popma JJ, Cutlip DE, Fitzgerald PJ
Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study. Am J Cardiol. 2007 Oct 22; 100(8B):56M-61M.
Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study.
Hong MK, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, Mintz GS, Keller MB, Leon MB
Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am Heart J. 1994 Jun; 127(6):1496-503.
Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts.
Lange RA, Cigarroa RG, Yancy CW, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD
Cocaine-induced coronary artery vasocontriction. New Engl J Med. 1989; 321:1557-1562.
Cocaine-induced coronary artery vasocontriction
PeriStent Restenosis Following Drug-Eluting Stents: Influence of Contributing Factors. J Am Coll Cardiol. 2004; in press.
PeriStent Restenosis Following Drug-Eluting Stents: Influence of Contributing Factors
Drudi LM, Ades M, Asgar A, Perrault L, Lauck S, Webb JG, Rassi A, Lamy A, Noiseux N, Peterson MD, Labinaz M, Lefèvre T, Popma JJ, Kim DH, Martucci G, Piazza N, Afilalo J
Interaction Between Frailty and Access Site in Older Adults Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2018 11 12; 11(21):2185-2192.
Interaction Between Frailty and Access Site in Older Adults Undergoing Transcatheter Aortic Valve Replacement.
Kundi H, Strom JB, Valsdottir LR, Elmariah S, Popma JJ, Shen C, Yeh RW
Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes. JACC Cardiovasc Interv. 2018 11 12; 11(21):2148-2156.
Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes.
Kandzari DE, Grantham JA, Karmpaliotis D, Lombardi W, Moses JW, Nicholson W, Cook S, Pershad A, Popma JJ
Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study. Coron Artery Dis. 2018 12; 29(8):618-623.
Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study.
Cardiovascular revascularization medicine : including molecular interventions
Primary MR remains undertreated. Cardiovasc Revasc Med. 2018 12; 19(8):905-906.
Pineda AM, Kevin Harrison J, Kleiman NS, Reardon MJ, Conte JV, O'Hair DP, Chetcuti SJ, Huang J, Yakubov SJ, Popma JJ, Beohar N
Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement. Catheter Cardiovasc Interv. 2019 03 01; 93(4):740-748.
Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
Kornowski R, Lansky AJ, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Popma JJ, Leon MB
Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris. Am J Cardiol. 1997 Jun 15; 79(12):1601-5.
Comparison of men versus women in cross-sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and lumen location in coronary arteries by intravascular ultrasound in patients with stable angina pectoris.
Carrozza JP, Hermiller JB, Linnemeier TJ, Popma JJ, Yock PG, Roubin GS, Dean LS, Kuntz RE, Robertson L, Ho KK, Cutlip DE, Baim DS
Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: report from the Advanced Cardiovascular Systems MultiLink stent pilot study. J Am Coll Cardiol. 1998 Jan; 31(1):50-6.
Quantitative coronary angiographic and intravascular ultrasound assessment of a new nonarticulated stent: report from the Advanced Cardiovascular Systems MultiLink stent pilot study.
Baim DS, Cutlip DE, Sharma SK, Ho KK, Fortuna R, Schreiber TL, Feldman RL, Shani J, Senerchia C, Zhang Y, Lansky AJ, Popma JJ, Kuntz RE
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT) Circulation. 1998 Feb 03; 97(4):322-31.
Final results of the Balloon vs Optimal Atherectomy Trial (BOAT)
Wong SC, Popma JJ, Pichard AD, Kent KM, Satler LF, Mintz GS, Chuang YC, Hong MK, Ditrano CJ, Leon MB
Comparison of clinical and angiographic outcomes after saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted stents. Circulation. 1995 Jan 15; 91(2):339-50.
Comparison of clinical and angiographic outcomes after saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted stents.
Mintz GS, Pichard AD, Kovach JA, Kent KM, Satler LF, Javier SP, Popma JJ, Leon MB
Impact of preintervention intravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease. Am J Cardiol. 1994 Mar 01; 73(7):423-30.
Impact of preintervention intravascular ultrasound imaging on transcatheter treatment strategies in coronary artery disease.
Kundi H, Valsdottir LR, Popma JJ, Cohen DJ, Strom JB, Pinto DS, Shen C, Yeh RW
Circulation. Cardiovascular quality and outcomes
Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e005048.
Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.
Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996 Aug 29; 335(9):624-30.
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.
Recertification in interventional cardiology. JACC Cardiovasc Interv. 2008 Jun; 1(3):332-4.
Recertification in interventional cardiology.
Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, Itescu S, Miller LW, Dinsmore JH, Dangas GD, Popma JJ, Hall JL, Holmes DR
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc Interv. 2010 Mar; 3(3):265-75.
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research.
Dangas GD, George JC, Weintraub W, Popma JJ
Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. JACC Cardiovasc Interv. 2010 Oct; 3(10):1096-9.
Timing of staged percutaneous coronary intervention in multivessel coronary artery disease.
Schaefer S, Taylor AL, Lee HR, Niggemann EH, Levine BD, Popma JJ, Mitchell JH, Hillis LD
Effect of increasing heart rate on left ventricular performance in patients with normal cardiac function. Am J Cardiol. 1988 Mar 01; 61(8):617-20.
Effect of increasing heart rate on left ventricular performance in patients with normal cardiac function.
Modern Management of Acute Myocardial Infarction in the Community Hospital, Anderson JL (Editor),
The role of coronary angioplasty in patients with acute myocardial infarction. Modern Management of Acute Myocardial Infarction in the Community Hospital, Anderson JL (Editor),. 1991.
The role of coronary angioplasty in patients with acute myocardial infarction
Preintervention arterial remodeling affects clinical outcome following stenting: an intravascular ultrasound study. J Am Coll Cardiol 2001 Mar 15;37(4):1031-5. 2001; 37(4):1031-5.
Durko AP, Reardon MJ, Kleiman NS, Popma JJ, Van Mieghem NM, Gleason TG, Bajwa T, O'Hair D, Brown DL, Ryan WH, Chang Y, De Leon SD, Kappetein AP
Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients. J Am Coll Cardiol. 2018 10 30; 72(18):2109-2119.
Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.
Ozaki Y, Keane D, Nobuyoshi M, Hamasaki N, Popma JJ, Serruys PW
Coronary lumen at six-month follow-up of a new radiopaque Cordis tantalum stent using quantitative angiography and intracoronary ultrasound. Am J Cardiol. 1995 Dec 01; 76(16):1135-43.
Coronary lumen at six-month follow-up of a new radiopaque Cordis tantalum stent using quantitative angiography and intracoronary ultrasound.
Lansky AJ, Mintz GS, Mehran R, Popma JJ, Pichard AD, Kent KM, Satler LF, Leon MB
Insights into the mechanism of restenosis after PTCA and stenting. Indian Heart J. 1998 Oct; 50 Suppl 1:104-8.
Insights into the mechanism of restenosis after PTCA and stenting.
Teirstein PS, Mann JT, Cundey PE, Schechter E, Jacobs WC, Grines CL, Stagaman DJ, Lansky AJ, Hultquist MA, Kusnick BA, Heuser RR, Kleinert HD, Popma J
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. Am J Cardiol. 1999 Jun 15; 83(12):1623-8.
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion.
Wainstein MV, Resnic FS, Lee MKY, Wainstein RV, Behrendt D, Ohno-Machado L, Kirshenbaum JM, Rogers C, Piana RN, Popma JJ
Lack of clinical efficacy of pharmacologic treatment of the no reflow phenomenon despite significant angiographic improvement. J Am Coll Cardiol. 2001; 37(2):83A.
Lack of clinical efficacy of pharmacologic treatment of the no reflow phenomenon despite significant angiographic improvement
Stent Complications [Record Supplied By Publisher. J Invasive Cardiol. 1998; 10(7):385-395.
Stent Complications [Record Supplied By Publisher
Popma JJ, Berger P, Ohman EM, Harrington RA, Grines C, Weitz JI
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 Sep;126(3 Suppl):576S-599S (. 2004; 126(3 Suppl):576S-599S.
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty. J Invasive Cardiol. 1997; 9(4):303-314.
Lipid-lowering therapy after coronary revascularization. Am J Cardiol. 2000 Aug 24; 86(4B):18H-28H.
Lipid-lowering therapy after coronary revascularization.
Kundi H, Popma JJ, Cohen DJ, Liu DC, Laham RJ, Pinto DS, Chu LM, Strom JB, Shen C, Yeh RW
Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries. Am J Cardiol. 2019 01 01; 123(1):132-138.
Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries.
Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Bucher TA, Griffin J, Leon MB
Mechanisms and immediate and long-term results of adjunct directional coronary atherectomy after rotational atherectomy. J Am Coll Cardiol. 1996 May; 27(6):1390-7.
Mechanisms and immediate and long-term results of adjunct directional coronary atherectomy after rotational atherectomy.
Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP, Chauhan MS, Rodriguez O, Kuntz RE
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001 Apr 17; 103(15):1967-71.
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.
Satler LF, Hoffmann R, Lansky A, Mintz GS, Popma JJ, Pichard AD, Kent KM, Hong MK, Korzak N, Horton K, Cabellion S, Leon MB
Carotid stent-assisted angioplasty: Preliminary technique, angiography, and intravascular ultrasound observations. J Invasive Cardiol 1996 Jan;8(1):23-30. 1996; 8(1):23-30.
Carotid stent-assisted angioplasty: Preliminary technique, angiography, and intravascular ultrasound observations
Heart Disease: A Textbook of Cardiovascular Medicine (7th Edition). Braunwald E, Zipes DP, Libby P (Editors).
Percutaneous Coronary and Valvular Intervention. Heart Disease: A Textbook of Cardiovascular Medicine (7th Edition). Braunwald E, Zipes DP, Libby P (Editors). 2004.
Bivalirudin in Percutaneous Coronary Interventions and Acute Coronary Syndromes: New Concepts, New Directions [Record Supplied By Publisher]. Curr Interv Cardiol Rep. 1999; 1(4):346-358.
Bivalirudin in Percutaneous Coronary Interventions and Acute Coronary Syndromes: New Concepts, New Directions [Record Supplied By Publisher]
Distal Protection Devices During Percutaneous Saphenous Vein Graft Intervention: Has a New Standard of Care Been Established? [Record Supplied By Publisher]. Curr Interv Cardiol Rep. 2001; 3(4):275-280.
Distal Protection Devices During Percutaneous Saphenous Vein Graft Intervention: Has a New Standard of Care Been Established? [Record Supplied By Publisher]
Chetcuti SJ, Deeb GM, Popma JJ, Yakubov SJ, Grossman PM, Patel HJ, Casale A, Dauerman HL, Resar JR, Boulware MJ, Dries-Devlin JL, Li S, Oh JK, Reardon MJ
Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis. JACC Cardiovasc Imaging. 2019 01; 12(1):67-80.
Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 2003 Jan 28; 107(3):381-3.
Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries.
De Cesare NB, Popma JJ, Holmes DR, Dick RJ, Whitlow PL, King SB, Pinkerton CA, Kereiakes DJ, Topol EJ, Haudenschild CC
Clinical angiographic and histologic correlates of ectasia after directional coronary atherectomy. Am J Cardiol. 1992 Feb 01; 69(4):314-9.
Clinical angiographic and histologic correlates of ectasia after directional coronary atherectomy.
Coskun AU, Yeghiazarians Y, Kinlay S, Clark ME, Ilegbusi OJ, Wahle A, Sonka M, Popma JJ, Kuntz RE, Feldman CL, Stone PH
Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans. Catheter Cardiovasc Interv. 2003 Sep; 60(1):67-78.
Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans.
Clinical trials of restenosis after coronary angioplasty. Circulation. 1991 Sep; 84(3):1426-36.
Clinical trials of restenosis after coronary angioplasty.
Lincoff AM, Popma JJ, Ellis SG, Vogel RA, Topol EJ
Percutaneous support devices for high risk or complicated coronary angioplasty. J Am Coll Cardiol. 1991 Mar 01; 17(3):770-80.
Percutaneous support devices for high risk or complicated coronary angioplasty.
Kundi H, Popma JJ, Khabbaz KR, Chu LM, Strom JB, Valsdottir LR, Shen C, Yeh RW
Association of Hospital Surgical Aortic Valve Replacement Quality With 30-Day and 1-Year Mortality After Transcatheter Aortic Valve Replacement. JAMA Cardiol. 2019 01 01; 4(1):16-22.
Association of Hospital Surgical Aortic Valve Replacement Quality With 30-Day and 1-Year Mortality After Transcatheter Aortic Valve Replacement.
Popma JJ, Coller BS, Ohman EM, Bittl JA, Weitz J, Kuntz RE, Leon MB
Antithrombotic therapy in patients undergoing coronary angioplasty. Chest. 1995 Oct; 108(4 Suppl):486S-501S.
Antithrombotic therapy in patients undergoing coronary angioplasty.
Mintz GS, Pichard AD, Kent KM, Kovach JA, Popma JJ, Satler LF, Leon MB
Transcatheter device synergy: preliminary experience with adjunct directional coronary atherectomy following high-speed rotational atherectomy or excimer laser angioplasty in the treatment of coronary artery disease. Cathet Cardiovasc Diagn. 1993; Suppl 1:37-44.
Transcatheter device synergy: preliminary experience with adjunct directional coronary atherectomy following high-speed rotational atherectomy or excimer laser angioplasty in the treatment of coronary artery disease.
Popma JJ, Brogan WC, Pichard AD, Satler LF, Kent KM, Mintz GS, Leon MB
Rotational coronary atherectomy of ostial stenoses. Am J Cardiol. 1993 Feb 15; 71(5):436-8.
Rotational coronary atherectomy of ostial stenoses.
Weisz G, Moses JW, Popma JJ, Mishkel G, Wilensky RL, Cohen B, Madyoon H, Roberts D, Leon MB
Do overlapping multiple sirolimus-eluting stents impact angiographic and clinical outcomes? Insights from the SIRIUS trial. J Am Coll Cardiol. 2003; 41(6):33A.
Do overlapping multiple sirolimus-eluting stents impact angiographic and clinical outcomes? Insights from the SIRIUS trial
Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, Cowley MJ, Raymond RE, Safian RD, Whitlow PL
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994 Dec; 90(6):2725-30.
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome.
Mintz GS, Pichard AD, Satler LF, Popma JJ, Kent KM, Leon MB
Three-dimensional intravascular ultrasonography: reconstruction of endovascular stents in vitro and in vivo. J Clin Ultrasound. 1993 Nov-Dec; 21(9):609-15.
Three-dimensional intravascular ultrasonography: reconstruction of endovascular stents in vitro and in vivo.
Popma JJ, Satler LF, Pichard AD, Kent KM, Campbell A, Chuang YC, Clark C, Merritt AJ, Bucher TA, Leon MB
Vascular complications after balloon and new device angioplasty. Circulation. 1993 Oct; 88(4 Pt 1):1569-78.
Vascular complications after balloon and new device angioplasty.
Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, DeFalco RA, Leon MB
Limitations of angiography in the assessment of plaque distribution in coronary artery disease: a systematic study of target lesion eccentricity in 1446 lesions. Circulation. 1996 Mar 01; 93(5):924-31.
Limitations of angiography in the assessment of plaque distribution in coronary artery disease: a systematic study of target lesion eccentricity in 1446 lesions.
Hong MK, Satler LF, Mintz GS, Wong SC, Kent KM, Pichard AD, Popma JJ, Leon MB
Treatment of spontaneous coronary artery dissection with intracoronary stenting. Am Heart J. 1996 Jul; 132(1 Pt 1):200-2.
Treatment of spontaneous coronary artery dissection with intracoronary stenting.
Stone PH, Coskun AU, Kinlay S, Popma JJ, Sonka M, Wahle A, Yeghiazarians Y, Maynard C, Kuntz RE, Feldman CL
Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study. Eur Heart J. 2007 Mar; 28(6):705-10.
Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study.
Introduction: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy. J Invasive Cardiol. 2008 Aug; 20(8 Suppl A):1A.
Introduction: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy.
Lansky A, Tuinenburg J, Costa M, Maeng M, Koning G, Popma J, Cristea E, Gavit L, Costa R, Rares A, Van Es GA, Lefevre T, Reiber H, Louvard Y, Morice MC
Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group. Catheter Cardiovasc Interv. 2009 Feb 01; 73(2):258-66.
Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group.
Popma JJ, Dangas GD, Tommaso CL, Bailes SC
Structure and function of the ACC Interventional Scientific Council and Section. JACC Cardiovasc Interv. 2008 Aug; 1(4):452-5.
Structure and function of the ACC Interventional Scientific Council and Section.
Care of the patient after coronary angioplasty. Ann Intern Med. 1989 Apr 01; 110(7):547-59.
Care of the patient after coronary angioplasty.
Popma JJ, Nathan S, Hagberg RC, Khabbaz KR
Hybrid myocardial revascularization: an integrated approach to coronary revascularization. Catheter Cardiovasc Interv. 2010 Mar 01; 75 Suppl 1:S28-34.
Hybrid myocardial revascularization: an integrated approach to coronary revascularization.
Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ
Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). Am J Cardiol. 2010 Apr 15; 105(8):1060-4.
Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).
Attizzani GF, Patel SM, Dangas GD, Szeto WY, Sorajja P, Reardon MJ, Popma JJ, Kodali S, Chenoweth S, Costa MA
Comparison of Local Versus General Anesthesia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry). Am J Cardiol. 2019 02 01; 123(3):419-425.
Comparison of Local Versus General Anesthesia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry).
Kundi H, Popma JJ, Valsdottir LR, Shen C, Faridi KF, Pinto DS, Yeh RW
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure. Can J Cardiol. 2018 12; 34(12):1648-1654.
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure.
Morales PA, Heuser RR, Laskey W, Bonan R, Lansky AJ, Popma JJ.
Treating in-stent restenosis in long coronary lesions. J Am Coll Cardiol. 2002; 39(5):14A.
Treating in-stent restenosis in long coronary lesions
Lansky AJ, Popma JJ, Mintz GS, Bucher TA, Kent KM, Pichard AD, Satler LF, Leon MB
Frequency and prognostic importance of creatine phosphokinase myocardial isoforms after successful balloon and new device coronary angioplasty. J Invasive Cardiol. 1996; 8(Suppl C):3C-9C.
Frequency and prognostic importance of creatine phosphokinase myocardial isoforms after successful balloon and new device coronary angioplasty
Sousa JE, Abizaid A, Feres F, Mattos LA, Tanajura LF, Sousa AGMR, Popma J, Fitzgerald P, Giorgianni JA, Rodney RA
REDOX Trial - Reduced Sirolimus Doses on the Bx VELOCITYTM Stent Four-Month Results. J Am Coll Cardiol. 2004; in press.
REDOX Trial - Reduced Sirolimus Doses on the Bx VELOCITYTM Stent Four-Month Results
Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Cohen DJ, Yeh RW
Circulation. Cardiovascular interventions
Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock. Circ Cardiovasc Interv. 2019 01; 12(1):e007270.
Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock.
Guerci AD, Spadaro LA, Popma JJ, Goodman KJ, Brundage BH, Budoff M, Lerner G, Vizza RF
Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol. 1997 Jan 15; 79(2):128-33.
Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults.
Stone GW, Brodie BR, Griffin JJ, Morice MC, Costantini C, St Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O'Neill WW, Grines CL
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol. 1998 Jan; 31(1):23-30.
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators.
Interrelation of coronary angiographic reference lumen size and intravascular ultrasound target lesion calcium. Am J Cardiol. 1998 Feb 15; 81(4):387-91.
Interrelation of coronary angiographic reference lumen size and intravascular ultrasound target lesion calcium.
Lansky AJ, Popma JJ, Cutlip D, Ho KK, Abizaid AS, Saucedo J, Zhang Y, Senerchia C, Kuntz RE, Leon MB, Baim DS
Comparative analysis of early and late angiographic outcomes using two quantitative algorithms in the Balloon versus Optimal Atherectomy Trial (BOAT). Am J Cardiol. 1999 Jun 15; 83(12):1611-6.
Comparative analysis of early and late angiographic outcomes using two quantitative algorithms in the Balloon versus Optimal Atherectomy Trial (BOAT).
Saucedo JF, Popma JJ, Kennard ED, Talley JD, Lansky A, Leon MB, Baim DS
Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry Report). Am J Cardiol. 2000 Jan 15; 85(2):166-71.
Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry Report).
Fukutomi T, Suzuki T, Popma JJ, Hosokawa H, Yokoya K, Inada T, Hayase M, Kondo H, Ito S, Suzuki S, Itoh M
Circulation journal : official journal of the Japanese Circulation Society
Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J. 2002 Apr; 66(4):349-56.
Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention.
Mauri L, Bonan R, Weiner BH, Legrand V, Bassand JP, Popma JJ, Niemyski P, Prpic R, Ho KK, Chauhan MS, Cutlip DE, Bertrand OF, Kuntz RE
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol. 2002 Nov 15; 90(10):1079-83.
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial.
Cutting balloon entrapment during treatment of in-stent restenosis: an unusual complication and its management. J Invasive Cardiol. 2005 Mar; 17(3):168-70.
Cutting balloon entrapment during treatment of in-stent restenosis: an unusual complication and its management.
Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu CJ, Chan C, Webster MW, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial. J Am Coll Cardiol. 2007 Apr 24; 49(16):1676-83.
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
Holmes DR, Kereiakes DJ, Laskey WK, Colombo A, Ellis SG, Henry TD, Popma JJ, Serruys PW, Kimura T, Williams DO, Windecker S, Krucoff MW
Thrombosis and drug-eluting stents: an objective appraisal. J Am Coll Cardiol. 2007 Jul 10; 50(2):109-18.
Thrombosis and drug-eluting stents: an objective appraisal.
Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R
Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2007 Nov 27; 50(22):2111-6.
Gender-specific outcomes after sirolimus-eluting stent implantation.
Kirtane AJ, Ellis SG, Dawkins KD, Colombo A, Grube E, Popma JJ, Fahy M, Leon MB, Moses JW, Mehran R, Stone GW
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. J Am Coll Cardiol. 2008 Feb 19; 51(7):708-15.
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
Gray WA, Yeung AC, Cutlip DE, Popma JJ, Fitzgerald PJ, Williams DO, Heuer H, O'Shaughnessy CD, Overlie PA, Mann JT, Cannon LA, Hermiller JB, Henry TD, Whitbourn R, Stuckey TD, Midei MG, Coe J, Schwartz LB
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial. Int J Cardiol. 2012 May 17; 157(1):96-101.
A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial.
Sharma SK, Bolduan RW, Patel MR, Martinsen BJ, Azemi T, Giugliano G, Resar JR, Mehran R, Cohen DJ, Popma JJ, Waksman R
Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results. Catheter Cardiovasc Interv. 2019 Aug 01; 94(2):187-194.
Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.
Weintraub WS, Grau-Sepulveda MV, Weiss JM, Delong ER, Peterson ED, O'Brien SM, Kolm P, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Garratt KN, Moussa ID, Edwards FH, Dangas GD
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation. 2012 Mar 27; 125(12):1501-10.
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry.
Kim DH, Afilalo J, Shi SM, Popma JJ, Khabbaz KR, Laham RJ, Grodstein F, Guibone K, Lux E, Lipsitz LA
Evaluation of Changes in Functional Status in the Year After Aortic Valve Replacement. JAMA Intern Med. 2019 03 01; 179(3):383-391.
Evaluation of Changes in Functional Status in the Year After Aortic Valve Replacement.
Amrane H, Deeb GM, Popma JJ, Yakubov SJ, Gleason TG, Van Mieghem NM, Reardon MJ
Causes of death in intermediate-risk patients: The Randomized Surgical Replacement and Transcatheter Aortic Valve Implantation Trial. J Thorac Cardiovasc Surg. 2019 09; 158(3):718-728.e3.
Causes of death in intermediate-risk patients: The Randomized Surgical Replacement and Transcatheter Aortic Valve Implantation Trial.
Sousa JE, Abizaid A, Costa MA, Sousa A, Feres F, Mattos LA, Pinto I, Seixas AC, Tanajura LF, Falotico R, Popma J, Serruys PW
Late Four-Year Follow-Up From the First-in-Man Experience After Implantation of Sirolimus-Eluting Stents. J Am Coll Cardiol. 2004; in press.
Late Four-Year Follow-Up From the First-in-Man Experience After Implantation of Sirolimus-Eluting Stents
Kwok OH, Chow WH, Lee CH, Ng W, Law TC, Chiu A, Popma JJ
First-in-human study of angiopeptin-eluting stents: A quantitative coronary angiography and volumetric intravascular ultrasound study. J Am Coll Cardiol. 2003; 41(6):6A.
First-in-human study of angiopeptin-eluting stents: A quantitative coronary angiography and volumetric intravascular ultrasound study
Brogan WC, Popma JJ, Pichard AD, Satler LF, Kent KM, Mintz GS, Leon MB
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty. Am J Cardiol. 1993 Apr 01; 71(10):794-8.
Rotational coronary atherectomy after unsuccessful coronary balloon angioplasty.
Fuessl RT, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
In vivo validation of intravascular ultrasound length measurements using a motorized transducer pullback system. Am J Cardiol. 1996 May 15; 77(12):1115-8.
In vivo validation of intravascular ultrasound length measurements using a motorized transducer pullback system.
Shi SM, Sung M, Afilalo J, Lipsitz LA, Kim CA, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Lee J, Marcantonio ER, Kim DH
Journal of the American Geriatrics Society
Delirium Incidence and Functional Outcomes After Transcatheter and Surgical Aortic Valve Replacement. J Am Geriatr Soc. 2019 07; 67(7):1393-1401.
Delirium Incidence and Functional Outcomes After Transcatheter and Surgical Aortic Valve Replacement.
Pighi M, Piazza N, Martucci G, Lachapelle K, Perrault LP, Asgar AW, Lauck S, Webb JG, Popma JJ, Kim DH, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Noiseux N, Trnkus A, Afilalo J
Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes. 2019 03; 12(3):e005363.
Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement.
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019 05 02; 380(18):1706-1715.
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
Strom JB, Tamez H, Zhao Y, Valsdottir LR, Curtis J, Brennan JM, Shen C, Popma JJ, Mauri L, Yeh RW
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study. Am Heart J. 2019 06; 212:64-71.
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.
Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, Shen C, Choi E, Yeh RW
Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort. Eur Heart J. 2019 07 14; 40(27):2231-2239.
Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort.
Sorajja P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Popma JJ, Blanke P, Leipsic J, Muller D
Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients. J Am Coll Cardiol. 2019 03 26; 73(11):1250-1260.
Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients.
Head SJ, Reardon MJ, Deeb GM, Van Mieghem NM, Popma JJ, Gleason TG, Williams MR, Radhakrishnan S, Fremes S, Oh JK, Chang Y, Boulware MJ, Kappetein AP
Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch. Circ Cardiovasc Interv. 2019 04; 12(4):e007396.
Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
Sathananthan J, Lauck S, Piazza N, Martucci G, Kim DH, Popma JJ, Asgar AW, Perrault LP, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Noiseux N, Généreux P, Webb JG, Afilalo J
Habitual Physical Activity in Older Adults Undergoing TAVR: Insights From the FRAILTY-AVR Study. JACC Cardiovasc Interv. 2019 04 22; 12(8):781-789.
Habitual Physical Activity in Older Adults Undergoing TAVR: Insights From the FRAILTY-AVR Study.
Laird JR, Loja M, Zeller T, Niazi KAK, Foster MT, Ansel G, Stone DH, Dave RM, Popma JJ, Jaff MR, Massaro JM
iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study. J Vasc Interv Radiol. 2019 Jun; 30(6):822-829.e4.
iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study.
Katz Silver Family Professor of Medicine in the Field of Outcomes Research in Cardiology
Chen Z, Guo W, Jiang W, Wang F, Fu W, Zou Y, Deckers S, Li P, Popma JJ, Jaff MR
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population. J Endovasc Ther. 2019 08; 26(4):471-478.
IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.
Reardon MJ, Heijmen RH, Van Mieghem NM, Williams MR, Yakubov SJ, Watson D, Kleiman NS, Conte J, Chawla A, Hockmuth D, Petrossian G, Robinson N, Kappetein AP, Li S, Popma JJ
Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial. JAMA Cardiol. 2019 08 01; 4(8):810-814.
Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
Hosler QP, Maltagliati AJ, Shi SM, Afilalo J, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Kim DH
A Practical Two-Stage Frailty Assessment for Older Adults Undergoing Aortic Valve Replacement. J Am Geriatr Soc. 2019 10; 67(10):2031-2037.
A Practical Two-Stage Frailty Assessment for Older Adults Undergoing Aortic Valve Replacement.
David S. Ginsburg Associate Professor of Surgery in the Field of Cardiothoracic Surgery
Kundi H, Cohen DJ, Strom JB, Valsdottir L, Shen C, Choi E, Popma JJ, Yeh RW
Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR. Int J Cardiol. 2019 10 01; 292:68-72.
Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR.
George H. A. Clowes, Jr. Professor of Surgery
Allan and Gill Gray Professor of Medicine in the Field of Cardiology
Anwaruddin S, Desai ND, Szeto WY, Hermiller JB, Sorajja P, Kodali S, Popma JJ, Giri J, Herrmann HC, Tang GHL, Rame JE, McCarthy FH, Zhang AQ, Reardon MJ
Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry). Am J Cardiol. 2019 09 01; 124(5):781-788.
Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry).
Tang GHL, Reardon MJ, Kodali SK, Hermiller JB, Sorajja P, Szeto WY, Zhang A, Popma JJ
Comparison of Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Implantation With 31-mm CoreValve Versus 34-mm Evolut R Bioprostheses from the STS/ACC TVT Registry. Am J Cardiol. 2019 10 01; 124(7):1091-1098.
Comparison of Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Implantation With 31-mm CoreValve Versus 34-mm Evolut R Bioprostheses from the STS/ACC TVT Registry.
Kiefer NJ, Salber GC, Burke GM, Chang JD, Guibone KA, Popma JJ, Hahn RT, Pinto DS, Strom JB
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
The Impact of Basal Septal Hypertrophy on Outcomes after Transcatheter Aortic Valve Replacement. J Am Soc Echocardiogr. 2019 11; 32(11):1416-1425.
The Impact of Basal Septal Hypertrophy on Outcomes after Transcatheter Aortic Valve Replacement.
Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply. N Engl J Med. 2019 08 15; 381(7):685.
Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply.
Kandzari DE, Karmpaliotis D, Kini AS, Moses JW, Tummala PE, Grantham JA, Orr C, Lombardi W, Nicholson WJ, Lembo NJ, Popma JJ, Wang J, Zhao W, McGreevy R
Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial. Catheter Cardiovasc Interv. 2019 Oct 01; 94(4):509-515.
Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial.
Søndergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstrøm T
Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI Trial. Circulation. 2019 Oct 15; 140(16):1296-1305.
Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI Trial.
Kundi H, Faridi KF, Wang Y, Wadhera RK, Valsdottir LR, Popma JJ, Kramer DB, Yeh RW
Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States. Circulation. 2019 09 10; 140(11):969-971.
Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States.
Kereiakes DJ, Ellis SG, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, Tan SH, Ediebah DE, Simonton C, Stone GW
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial. Circulation. 2019 12 03; 140(23):1895-1903.
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.
Burke DA, Kundi H, Almonacid A, O'Neill W, Moses J, Kleiman N, Dixon S, Palacios I, Guzman LA, Ohman EM, Popma JJ, Pinto DS
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial. JACC Cardiovasc Interv. 2019 10 14; 12(19):1985-1987.
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial.
Dauerman HL, Deeb GM, O'Hair DP, Waksman R, Yakubov SJ, Kleiman NS, Chetcuti SJ, Hermiller JB, Bajwa T, Khabbaz K, de Marchena E, Salerno T, Dries-Devlin JL, Li S, Popma JJ, Reardon MJ
Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses. Circ Cardiovasc Interv. 2019 10; 12(10):e008155.
Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.
Lindman BR, Goel K, Bermejo J, Beckman J, O'Leary J, Barker CM, Kaiser C, Cavalcante JL, Elmariah S, Huang J, Hickey GL, Adams DH, Popma JJ, Reardon MJ
Journal of the American Heart Association
Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality. J Am Heart Assoc. 2019 11 05; 8(21):e014020.
Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality.
Strom JB, Zhao Y, Faridi KF, Tamez H, Butala NM, Valsdottir LR, Curtis J, Brennan JM, Shen C, Boulware M, Popma JJ, Yeh RW
Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study. Circ Cardiovasc Interv. 2019 11; 12(11):e008231.
Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study.
Russo JJ, Prasad M, Doshi D, Karmpaliotis D, Parikh MA, Ali ZA, Popma JJ, Pershad A, Ohman EM, Douglas PS, O'Neill WW, Leon MB, Moses JW, Kirtane AJ
Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. Catheter Cardiovasc Interv. 2020 10 01; 96(4):764-770.
Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
Rymer JA, Mandawat A, Abbott JD, Cohen MG, Davies JE, Gilchrist IC, Jolly SS, Popma JJ, Al-Khalidi HR, Rao SV, Kong D, Krucoff M
Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial. Am Heart J. 2019 12; 218:84-91.
Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial.
Heart Team 2.0. EuroIntervention. 2019 Nov 20; 15(10):825-827.
Onuma Y, Honda Y, Asano T, Shiomi H, Kozuma K, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Hanaoka KI, Tanabe K, Okada K, Kitahara H, Ono M, Kusano H, Rapoza R, Simonton C, Popma JJ, Stone GW, Fitzgerald PJ, Serruys PW, Kimura T
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. JACC Cardiovasc Interv. 2020 01 13; 13(1):116-127.
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.
Ito S, Nkomo VT, Orsinelli DA, Lin G, Cavalcante J, Popma JJ, Adams DH, Checuti SJ, Deeb GM, Boulware M, Huang J, Little SH, Cohen SA, Reardon MJ, Oh JK
Impact of Stroke Volume Index and Left Ventricular Ejection Fraction on Mortality After Aortic Valve Replacement. Mayo Clin Proc. 2020 01; 95(1):69-76.
Impact of Stroke Volume Index and Left Ventricular Ejection Fraction on Mortality After Aortic Valve Replacement.
Forrest JK, Kaple RK, Tang GHL, Yakubov SJ, Nazif TM, Williams MR, Zhang A, Popma JJ, Reardon MJ
Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2020 01 27; 13(2):170-179.
Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry.
Shi S, Festa N, Afilalo J, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Kim DH
Comparative utility of frailty to a general prognostic score in identifying patients at risk for poor outcomes after aortic valve replacement. BMC Geriatr. 2020 02 03; 20(1):38.
Comparative utility of frailty to a general prognostic score in identifying patients at risk for poor outcomes after aortic valve replacement.
Van Mieghem NM, Popma JJ, Deeb GM, Yakubov SJ, Serruys PW, Windecker S, Søndergaard L, Mumtaz M, Gada H, Chetcuti S, Kleiman NS, Kodali S, George I, Teefy P, Kiaii B, Oh JK, Kappetein AP, Chang Y, Mugglin AS, Reardon MJ
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC Cardiovasc Interv. 2020 02 10; 13(3):323-331.
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial.
Kapadia M, Shi SM, Afilalo J, Popma JJ, Laham RJ, Guibone K, Kim DH
Cognition, Frailty, and Functional Outcomes of Transcatheter Aortic Valve Replacement. Am J Med. 2020 10; 133(10):1219-1222.
Cognition, Frailty, and Functional Outcomes of Transcatheter Aortic Valve Replacement.
Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, Mumtaz M, Ramlawi B, Kleiman NS, Sorajja P, Askew J, Meduri CU, Kauten J, Melnitchouk S, Inglessis I, Huang J, Boulware M, Reardon MJ
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study. J Am Coll Cardiol. 2020 05 19; 75(19):2430-2442.
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
Latib A, Mangieri A, Vezzulli P, Spagnolo P, Sardanelli F, Fellegara G, Pagnesi M, Giannini F, Falini A, Gorla R, Montorfano M, Bedogni F, Colombo A, Popma J, Merhi WM, De Marco F
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 04 13; 13(7):860-868.
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
Deeb GM, Popma JJ, Chetcuti SJ, Yakubov SJ, Mumtaz M, Gleason TG, Williams MR, Gada H, Oh JK, Li S, Boulware MJ, Kappetein AP, Reardon MJ
Computed Tomography Annular Dimensions: A Novel Method to Compare Prosthetic Valve Hemodynamics. Ann Thorac Surg. 2020 11; 110(5):1502-1510.
Computed Tomography Annular Dimensions: A Novel Method to Compare Prosthetic Valve Hemodynamics.
Bendayan M, Messas N, Perrault LP, Asgar AW, Lauck S, Kim DH, Arora RC, Langlois Y, Piazza N, Martucci G, Lefèvre T, Noiseux N, Lamy A, Peterson MD, Labinaz M, Popma JJ, Webb JG, Afilalo J
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study. JACC Cardiovasc Interv. 2020 05 11; 13(9):1058-1068.
Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study.
Strom JB, Faridi KF, Butala NM, Zhao Y, Tamez H, Valsdottir LR, Brennan JM, Shen C, Popma JJ, Kazi DS, Yeh RW
Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study. Circulation. 2020 07 21; 142(3):203-213.
Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings From the EXTEND Study.
Angle JF, Gasparetto A, Yokoi H, Jaff MR, Popma JJ, Piegari GN, Iyengar SS, Ohki T
Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial. J Vasc Interv Radiol. 2020 Jun; 31(6):978-985.
Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
Butala NM, Strom JB, Faridi KF, Kazi DS, Zhao Y, Brennan JM, Popma JJ, Shen C, Yeh RW
Validation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 08 10; 13(15):1777-1785.
Validation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement.
Van Mieghem NM, Reardon MJ, Yakubov SJ, Heiser J, Merhi W, Windecker S, Makkar RR, Cheng W, Robbins M, Fail P, Feinberg E, Stoler RC, Hebeler R, Serruys PW, Popma JJ
Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial. EuroIntervention. 2020 Nov 20; 16(10):833-841.
Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial.
Yakubov SJ, Van Mieghem NM, Reardon MJ, Serruys PW, Gada H, Mumtaz M, Deeb GM, Kodali S, George I, Windecker S, Kleiman N, Chetcuti SJ, Sanchez C, Dauerman HL, Li S, Popma JJ
Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial). Am J Cardiol. 2020 09 15; 131:82-90.
Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial).
Attizzani GF, Dallan LAP, Markowitz A, Yakubov SJ, Deeb GM, Reardon MJ, Forrest JK, Mangi AA, Huang J, Popma JJ
Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve. JACC Cardiovasc Interv. 2020 08 10; 13(15):1816-1824.
Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve.
Tamez H, Secemsky EA, Valsdottir LR, Moussa ID, Song Y, Simonton CA, Gibson CM, Popma JJ, Yeh RW
Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries. EuroIntervention. 2021 Aug 06; 17(5):e380-e387.
Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries.
Rao A, Shi SM, Afilalo J, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Marcantonio ER, Kim DH
Physical Performance and Risk of Postoperative Delirium in Older Adults Undergoing Aortic Valve Replacement. Clin Interv Aging. 2020; 15:1471-1479.
Physical Performance and Risk of Postoperative Delirium in Older Adults Undergoing Aortic Valve Replacement.
Okada K, Honda Y, Kitahara H, Ikutomi M, Kameda R, Brooke Hollak M, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T
International journal of cardiology. Heart & vasculature
Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial. Int J Cardiol Heart Vasc. 2020 Dec; 31:100623.
Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial.
Forrest JK, Ramlawi B, Deeb GM, Zahr F, Song HK, Kleiman NS, Chetcuti SJ, Michelena HI, Mangi AA, Skiles JA, Huang J, Popma JJ, Reardon MJ
Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis. JAMA Cardiol. 2021 01 01; 6(1):50-57.
Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis.
Mumtaz M, Wyler von Ballmoos MC, Deeb GM, Popma JJ, Van Mieghem NM, Kleiman NS, Gleason TG, Chawla A, Hockmuth D, Zorn GL, Tadros P, Li S, Reardon MJ
The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve Replacement. Ann Thorac Surg. 2021 09; 112(3):778-785.
The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve Replacement.
Thourani VH, Edelman JJ, Holmes SD, Nguyen TC, Carroll J, Mack MJ, Kapadia S, Tang GHL, Kodali S, Kaneko T, Meduri CU, Forcillo J, Ferdinand FD, Fontana G, Suwalski P, Kiaii B, Balkhy H, Kempfert J, Cheung A, Borger MA, Reardon M, Leon MB, Popma JJ, Ad N
The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies. Innovations (Phila). 2021 Jan-Feb; 16(1):3-16.
The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies.
Cohen DL, Weinberg I, Uretsky S, Popma JJ, Almonacid A, Hadley G, Cohen SA, Townsend RR
Clinical research in cardiology : official journal of the German Cardiac Society
Imaging strategies for safety surveillance after renal artery denervation. Clin Res Cardiol. 2021 May; 110(5):609-619.
Imaging strategies for safety surveillance after renal artery denervation.
Ooms JF, Wang DD, Rajani R, Redwood S, Little SH, Chuang ML, Popma JJ, Dahle G, Pfeiffer M, Kanda B, Minet M, Hirsch A, Budde RP, De Jaegere PP, Prendergast B, O'Neill W, Van Mieghem NM
Computed Tomography-Derived 3D Modeling to Guide Sizing and Planning of Transcatheter Mitral Valve Interventions. JACC Cardiovasc Imaging. 2021 08; 14(8):1644-1658.
Computed Tomography-Derived 3D Modeling to Guide Sizing and Planning of Transcatheter Mitral Valve Interventions.
Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol. 2021 06 01; 77(21):2717-2746.
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021 05 14; 42(19):1825-1857.
Nishi T, Okada K, Kitahara H, Kameda R, Ikutomi M, Imura S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Ellis SG, Kereiakes DJ, Stone GW, Honda Y, Kimura T
Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials. J Cardiol. 2021 Sep; 78(3):224-229.
Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials.
D'Ascenzo F, Bruno F, Baldetti L, De Filippo O, Marengo G, Breviario S, Melillo F, Thyregod HGH, Thiele H, Sondergaard L, Popma JJ, Kodali S, Franchin L, Annaratone M, Marruncheddu L, Gallone G, Crimi G, La Torre M, Rinaldi M, Omedè P, Conrotto F, Salizzoni S, De Ferrari GM
Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis. Int J Cardiol. 2021 08 15; 337:90-98.
Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis.
Naidu SS, Baron SJ, Eng MH, Sathanandam SK, Zidar DA, Feldman DN, Ing FF, Latif F, Lim MJ, Henry TD, Rao SV, Dangas GD, Hermiller JB, Daggubati R, Shah B, Ang L, Aronow HD, Banerjee S, Box LC, Caputo RP, Cohen MG, Coylewright M, Duffy PL, Goldsweig AM, Hagler DJ, Hawkins BM, Hijazi ZM, Jayasuriya S, Justino H, Klein AJ, Kliger C, Li J, Mahmud E, Messenger JC, Morray BH, Parikh SA, Reilly J, Secemsky E, Shishehbor MH, Szerlip M, Yakubov SJ, Grines CL, Alvarez-Breckenridge J, Baird C, Baker D, Berry C, Bhattacharya M, Bilazarian S, Bowen R, Brounstein K, Cameron C, Cavalcante R, Culbertson C, Diaz P, Emanuele S, Evans E, Fletcher R, Fortune T, Gaiha P, Govender D, Gutfinger D, Haggstrom K, Herzog A, Hite D, Kalich B, Kirkland A, Kohler T, Laurisden H, Livolsi K, Lombardi L, Lowe S, Marhenke K, Meikle J, Moat N, Mueller M, Patarca R, Popma J, Rangwala N, Simonton C, Stokes J, Taber M, Tieche C, Venditto J, West NEJ, Zinn L
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank. Catheter Cardiovasc Interv. 2021 11 01; 98(5):904-913.
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank.
Burke GM, Araujo Silva B, Marum AA, Bortolotto AL, Nearing BD, Chen MJ, Fostello S, Popma JJ, Verrier RL, Chang JD
Speckle tracking strain and ECG heterogeneity correlate in transcatheter aortic valve replacement-induced left bundle branch blocks and right ventricular paced rhythms. Open Heart. 2021 10; 8(2).
Speckle tracking strain and ECG heterogeneity correlate in transcatheter aortic valve replacement-induced left bundle branch blocks and right ventricular paced rhythms.
O'Neill WW, Anderson M, Burkhoff D, Grines CL, Kapur NK, Lansky AJ, Mannino S, McCabe JM, Alaswad K, Daggubati R, Wohns D, Meraj PM, Pinto DS, Popma JJ, Moses JW, Schreiber TL, Magnus Ohman E
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices. Am Heart J. 2022 06; 248:139-149.
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices.
Kaneko T, Vemulapalli S, Kohsaka S, Shimamura K, Stebbins A, Kumamaru H, Nelson AJ, Kosinski A, Maeda K, Bavaria JE, Saito S, Reardon MJ, Kuratani T, Popma JJ, Inohara T, Thourani VH, Carroll JD, Shimizu H, Takayama M, Leon MB, Mack MJ, Sawa Y
Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT. J Am Heart Assoc. 2022 03 15; 11(6):e023848.
Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT.
Simonato M, Vemulapalli S, Ben-Yehuda O, Wu C, Wood L, Popma J, Feldman T, Krohn C, Hardy KM, Guibone K, Christensen B, Alu MC, Chen S, Ng VG, Chau KH, Shahim B, Vincent F, MacMahon J, James S, Mack M, Leon MB, Thourani VH, Carroll J, Krucoff M
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. Ann Thorac Surg. 2022 05; 113(5):1730-1742.
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry.
Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry. JACC Cardiovasc Interv. 2022 04 11; 15(7):685-697.
Herrmann HC, Pibarot P, Wu C, Hahn RT, Tang GHL, Abbas AE, Playford D, Ruel M, Jilaihawi H, Sathananthan J, Wood DA, De Paulis R, Bax JJ, Rodes-Cabau J, Cameron DE, Chen T, Del Nido PJ, Dweck MR, Kaneko T, Latib A, Moat N, Modine T, Popma JJ, Raben J, Smith RL, Tchetche D, Thomas MR, Vincent F, Yoganathan A, Zuckerman B, Mack MJ, Leon MB
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 08 02; 80(5):527-544.
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review.
O'Hair D, Yakubov SJ, Grubb KJ, Oh JK, Ito S, Deeb GM, Van Mieghem NM, Adams DH, Bajwa T, Kleiman NS, Chetcuti S, Søndergaard L, Gada H, Mumtaz M, Heiser J, Merhi WM, Petrossian G, Robinson N, Tang GHL, Rovin JD, Little SH, Jain R, Verdoliva S, Hanson T, Li S, Popma JJ, Reardon MJ
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. JAMA Cardiol. 2023 02 01; 8(2):111-119.
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk.
Forrest JK, Deeb GM, Yakubov SJ, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Teirstein PS, DeFrain M, Muppala M, Rutkin BJ, Chawla A, Jenson B, Chetcuti SJ, Stoler RC, Poulin MF, Khabbaz K, Levack M, Goel K, Tchétché D, Lam KY, Tonino PAL, Ito S, Oh JK, Huang J, Popma JJ, Kleiman N, Reardon MJ
3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. J Am Coll Cardiol. 2023 05 02; 81(17):1663-1674.
3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
Vemulapalli S, Simonato M, Ben Yehuda O, Wu C, Feldman T, Popma JJ, Sundareswaren K, Krohn C, Hardy KM, Guibone K, Christensen B, Alu MC, Ng VG, Chau KH, Chen S, Shahim B, Vincent F, MacMahon J, James S, Mack M, Leon MB, Thourani VH, Carroll J, Krucoff MW
Minimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR. JACC Cardiovasc Interv. 2023 06 26; 16(12):1437-1447.
Minimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR.
Sharma RK, Laham RJ, Sorajja P, Shah B, Garcia S, Jain R, Fender EA, Philip F, Eisenberg R, Popma JJ, Chetcuti S
Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve Replacement. Am J Cardiol. 2023 12 01; 208:37-43.
Echocardiographic and Clinical Outcomes in Symptomatic Patients With Less Than Severe Aortic Stenosis After Supra-Annular Self-Expanding Transcatheter Aortic Valve Replacement.
Tang GHL, Spencer J, Rogers T, Grubb KJ, Gleason P, Gada H, Mahoney P, Dauerman HL, Forrest JK, Reardon MJ, Blanke P, Leipsic JA, Abdel-Wahab M, Attizzani GF, Puri R, Caskey M, Chung CJ, Chen YH, Dudek D, Allen KB, Chhatriwalla AK, Htun WW, Blackman DJ, Tarantini G, Zhingre Sanchez J, Schwartz G, Popma JJ, Sathananthan J
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study. Circ Cardiovasc Interv. 2023 11; 16(11):e013238.
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study.
Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis. Front Cardiovasc Med. 2023; 10:1295274.
Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis.
Heart Failure after Transcatheter Aortic Valve Implantation: Application of the Most Impactful Strain Imaging Techniques. CASE (Phila). 2024 Jan; 8(1):4-10.
Heart Failure after Transcatheter Aortic Valve Implantation: Application of the Most Impactful Strain Imaging Techniques.
North American view on the European Sentinel Registry of the Transcatheter Valve Implantation pilot study. EuroIntervention. 2013 Apr 22; 8(12):1353, 1355.
North American view on the European Sentinel Registry of the Transcatheter Valve Implantation pilot study.
Modine T, Tchétché D, Van Mieghem NM, Deeb GM, Chetcuti SJ, Yakubov SJ, Sorajja P, Gada H, Mumtaz M, Ramlawi B, Bajwa T, Crouch J, Teirstein PS, Kleiman NS, Iskander A, Bagur R, Chu MWA, Berthoumieu P, Sudre A, Adrichem R, Ito S, Huang J, Popma JJ, Forrest JK, Reardon MJ
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients. Circ Cardiovasc Interv. 2024 Nov; 17(11):e014018.
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients.
Yakubov SJ, Van Mieghem NM, Oh JK, Ito S, Grubb KJ, O'Hair D, Forrest JK, Gada H, Mumtaz M, Deeb GM, Tang GHL, Rovin JD, Jain R, Windecker S, Skelding KA, Kleiman NS, Chetcuti SJ, Dedrick A, Boatman SV, Popma JJ, Reardon MJ
Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at = Intermediate Risk. J Am Coll Cardiol. 2025 Apr 08; 85(13):1419-1430.
Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at = Intermediate Risk.
Kim CA, Rasania SP, Afilalo J, Popma JJ, Lipsitz LA, Kim DH
Functional status and quality of life after transcatheter aortic valve replacement: a systematic review. Ann Intern Med. 2014 Feb 18; 160(4):243-54.
Functional status and quality of life after transcatheter aortic valve replacement: a systematic review.
Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, Popma JJ, Ferrucci L, Forman DE
Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014 Mar 04; 63(8):747-62.
Frailty assessment in the cardiovascular care of older adults.
Litmanovich DE, Ghersin E, Burke DA, Popma J, Shahrzad M, Bankier AA
Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist. Insights Imaging. 2014 Feb; 5(1):123-45.
Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist.
Dangas GD, Kini AS, Sharma SK, Henriques JP, Claessen BE, Dixon SR, Massaro JM, Palacios I, Popma JJ, Ohman M, Stone GW, O'Neill WW
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014 Jan 15; 113(2):222-8.
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
Henriques JP, Ouweneel DM, Naidu SS, Palacios IF, Popma J, Ohman EM, O'Neill WW
Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study. Am Heart J. 2014 Apr; 167(4):472-479.e5.
Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study.
Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK
Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 08; 370(19):1790-8.
Transcatheter aortic-valve replacement with a self-expanding prosthesis.
Laird JR, Jain A, Zeller T, Feldman R, Scheinert D, Popma JJ, Armstrong EJ, Jaff MR
Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial. J Endovasc Ther. 2014 Apr; 21(2):202-12.
Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Coselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20; 63(19):1972-81.
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
Cohen MG, Ghatak A, Kleiman NS, Naidu SS, Massaro JM, Kirtane AJ, Moses J, Magnus Ohman E, Džavík V, Palacios IF, Heldman AW, Popma JJ, O'Neill WW
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ?? study. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1057-64.
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ?? study.
Edwards FH, Shahian DM, Grau-Sepulveda MV, Grover FL, Mayer JE, O'Brien SM, DeLong E, Peterson ED, McKay C, Shaw RE, Garratt KN, Dangas GD, Messenger J, Klein LW, Popma JJ, Weintraub WS
Composite outcomes in coronary bypass surgery versus percutaneous intervention. Ann Thorac Surg. 2014 Jun; 97(6):1983-8; discussion 1988-90.
Composite outcomes in coronary bypass surgery versus percutaneous intervention.
Fontana GP, Kundi H, Manoukian SV, Bowers B, Dewey TM, Klodell CT, Reddy VS, Riddick JA, Alvarez JA, Chenier MS, Groh MA, Nores MA, Loyalka P, Zidar FJ, Thompson JB, Alu MC, Cohen DJ, Granada JF, Leon MB, Popma JJ, Kar S
Structural heart : the journal of the Heart Team
Outcomes After Transcatheter Aortic Valve Replacement Among Medicare Beneficiaries: The Impact of Frailty and Social Vulnerability. Struct Heart. 2025 Aug; 9(8):100685.
Outcomes After Transcatheter Aortic Valve Replacement Among Medicare Beneficiaries: The Impact of Frailty and Social Vulnerability.
Kundi H, Popma JJ, Granada JF, Leon MB, Kodesh A, Ascione G, George I, Latib A, Thompson JB, Popma A, Alu MC, Cohen DJ
Outcomes in Older Patients Undergoing Surgical Aortic Valve Replacement With Concomitant Procedures. J Am Coll Cardiol. 2025 Jul 29; 86(4):280-283.
Outcomes in Older Patients Undergoing Surgical Aortic Valve Replacement With Concomitant Procedures.
Backer O, Khokhar AA, Bieliauskas G, Latib A, Puri R, Shaburishvili T, Zhividze M, Zirakashvili T, Asgar A, Krishnaswamy A, Garcia SA, Hahn RT, Mahoney PD, Waggoner T, Ailawadi G, Chetcuti S, Kim WK, Cavalcante J, Feldt K, Popma JJ, Coisne A, Meier D, Meduri CU, Windecker S, Reardon MJ, Bapat VN
Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli. EuroIntervention. 2026 Feb 02; 22(3):e150-e160.
Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli.
Mangner N, Sharma SK, O'Connor C, Kaki A, Dangas GD, Moses JW, Mahmud E, Tarantini G, Achenbach S, Pocock SJ, O'Neill WW, Grines CL, Lansky AJ, Wollmuth JR, Narula J, Karmpaliotis DI, Faraz HA, Basir MB, Bharadwaj AS, Ali ZA, Simonton C, Bilazarian SD, Kapur NK, Chapman RC, Bentley D, Popma JJ, Maehara A, Windecker S, Stone GW
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trial. EuroIntervention. 2025 Sep 30.
Mechanical circulatory support in high-risk elective PCI: rationale and design of the PROTECT IV trial.
Kundi H, Cohen DJ, Leon MB, Kodesh A, Popma A, von Stein P, Redfors B, Ranard LS, Alu MC, Thompson JB, von Stein J, Granada JF, Popma JJ
Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States. JACC Cardiovasc Interv. 2025 Sep 22; 18(18):2241-2252.
Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States.
Chrysant GS, Bates MC, Sullivan TM, Bachinsky WB, Popma JJ, Peng L, Omran HL, Jaff MR
Journal of clinical hypertension (Greenwich, Conn.)
Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. J Clin Hypertens (Greenwich). 2014 Jul; 16(7):497-503.
Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.
Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 09 04; 371(10):967-8.
Pracon R, Opolski MP, Mintz GS, Pregowski J, Kruk M, Popma JJ, Mandinov L, Wang H, Ellis SG, Grube E, Dawkins KD, Stone GW, Weissman NJ
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials. J Invasive Cardiol. 2014 Oct; 26(10):501-11.
Serial intravascular ultrasound analysis of stent strut distribution and fracture: an integrated analysis of the taxus IV, V, and VI trials.
Prosthesis-patient mismatch after "high-risk" aortic valve replacement. J Am Coll Cardiol. 2014 Sep 30; 64(13):1335-8.
Prosthesis-patient mismatch after "high-risk" aortic valve replacement.
Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Khabbaz K, Tadros P, Zorn GL, Merhi W, Heiser J, Petrossian G, Robinson N, Maini B, Mumtaz M, Lee JS, Gleason TG, Resar J, Conte J, Watson D, Chenoweth S, Popma JJ
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2869-76.e1-7.
Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery.
Two cases of heart failure after implantation of a CoreValve prosthesis. N Engl J Med. 2015 03 12; 372(11):1080-1.
Two cases of heart failure after implantation of a CoreValve prosthesis.
Garcia L, Jaff MR, Metzger C, Sedillo G, Pershad A, Zidar F, Patlola R, Wilkins RG, Espinoza A, Iskander A, Khammar GS, Khatib Y, Beasley R, Makam S, Kovach R, Kamat S, Leon LR, Eaves WB, Popma JJ, Mauri L, Donohoe D, Base CC, Rosenfield K
Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. Circ Cardiovasc Interv. 2015 May; 8(5).
Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.
Kovacic JC, Kini A, Banerjee S, Dangas G, Massaro J, Mehran R, Popma J, O'Neill WW, Sharma SK
Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. J Interv Cardiol. 2015 Feb; 28(1):32-40.
Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial.
Kandzari DE, Kini AS, Karmpaliotis D, Moses JW, Tummala PE, Grantham JA, Orr C, Lombardi W, Nicholson WJ, Lembo NJ, Popma JJ, Wang J, Larracas C, Rutledge DR
Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions). JACC Cardiovasc Interv. 2015 May; 8(6):761-769.
Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).
Bartorelli AL, Trabattoni D, Almonacid A, Fabbiocchi F, Montorsi P, Galli S, Grancini L, Ravagnani P, Mintz GS, Kaplan AV, Popma JJ, Maehara A
Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study. Catheter Cardiovasc Interv. 2015 Mar; 85(4):544-53.
Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
Henriques JP, Claessen BE, Dangas GD, Kirtane AJ, Popma JJ, Massaro JM, Cohen BM, Ohman EM, Moses JW, O'Neill WW
Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. Int J Cardiol. 2015; 189:272-8.
Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial.
Osnabrugge RL, Arnold SV, Reynolds MR, Magnuson EA, Wang K, Gaudiani VA, Stoler RC, Burdon TA, Kleiman N, Reardon MJ, Adams DH, Popma JJ, Cohen DJ
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial. JACC Cardiovasc Interv. 2015 Feb; 8(2):315-323.
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB, Chetcuti S, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2015 Jul 14; 66(2):113-21.
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.
Arnold SV, Reynolds MR, Wang K, Magnuson EA, Baron SJ, Chinnakondepalli KM, Reardon MJ, Tadros PN, Zorn GL, Maini B, Mumtaz MA, Brown JM, Kipperman RM, Adams DH, Popma JJ, Cohen DJ
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial. JACC Cardiovasc Interv. 2015 Aug 17; 8(9):1207-1217.
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
Kereiakes DJ, Ellis SG, Popma JJ, Fitzgerald PJ, Samady H, Jones-McMeans J, Zhang Z, Cheong WF, Su X, Ben-Yehuda O, Stone GW
Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial. Am Heart J. 2015 Oct; 170(4):641-651.e3.
Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.
Yakubov SJ, Adams DH, Watson DR, Reardon MJ, Kleiman NS, Heimansohn D, Hermiller J, Hughes GC, Harrison JK, Coselli J, Diez J, Schreiber T, Gleason TG, Conte J, Deeb GM, Huang J, Oh J, Byrne T, Caskey M, Popma JJ
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery. J Am Coll Cardiol. 2015 Sep 22; 66(12):1327-34.
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.
Piazza N, Treede H, Moat N, Sorajja P, Popma J, Grube E, Bolling S, Adams D
The Medtronic transcatheter mitral valve implantation system. EuroIntervention. 2015 Sep; 11 Suppl W:W80-1.
The Medtronic transcatheter mitral valve implantation system.
Daubert MA, Massaro J, Liao L, Pershad A, Mulukutla S, Magnus Ohman E, Popma J, O'Neill WW, Douglas PS
High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. Am Heart J. 2015 Sep; 170(3):550-8.
High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.
Cohen MG, Matthews R, Maini B, Dixon S, Vetrovec G, Wohns D, Palacios I, Popma J, Ohman EM, Schreiber T, O'Neill WW
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. Am Heart J. 2015 Nov; 170(5):872-9.
Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
Ellis SG, Kereiakes DJ, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med. 2015 Nov 12; 373(20):1905-15.
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015 Dec 14; 36(47):3332-42.
A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.
Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ
Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging. 2015 Dec; 8(12):1364-1375.
Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial.
Conte JV, Gleason TG, Resar JR, Adams DH, Deeb GM, Popma JJ, Hughes GC, Zorn GL, Reardon MJ
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. Ann Thorac Surg. 2016 Jan; 101(1):72-9; discussion 79.
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting.
Reynolds MR, Lei Y, Wang K, Chinnakondepalli K, Vilain KA, Magnuson EA, Galper BZ, Meduri CU, Arnold SV, Baron SJ, Reardon MJ, Adams DH, Popma JJ, Cohen DJ
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jan 05; 67(1):29-38.
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
Ohki T, Angle JF, Yokoi H, Jaff MR, Popma J, Piegari G, Kanaoka Y
One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study). J Vasc Surg. 2016 Feb; 63(2):370-6.e1.
One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).
Shammas NW, Shammas GA, Banerjee S, Popma JJ, Mohammad A, Jerin M
JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study. J Endovasc Ther. 2016 Apr; 23(2):339-46.
JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
Zorn GL, Little SH, Tadros P, Deeb GM, Gleason TG, Heiser J, Kleiman NS, Oh JK, Popma JJ, Adams D, Huang J, Reardon MJ
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1014-22, 1023.e1-3.
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis.
Moore WS, Popma JJ, Roubin GS, Voeks JH, Cutlip DE, Jones M, Howard G, Brott TG
Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy. J Vasc Surg. 2016 Apr; 63(4):851-7, 858.e1.
Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy.
Shavelle DM, Kirtane AJ, Schreiber TL, Kapasi NK, O'Neill WW, Moses JW, Popma J, Matthews RV
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study. J Invasive Cardiol. 2016 May; 28(5):187-92.
Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study.
Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jun 07; 67(22):2565-74.
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
Lammer J, Bosiers M, Deloose K, Schmidt A, Zeller T, Wolf F, Lansink W, Sauguet A, Vermassen F, Lauwers G, Scheinert D, Popma JJ, McGreevy R, Rapoza R, Schwartz LB, Jaff MR
Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results. JACC Cardiovasc Interv. 2016 06 13; 9(11):1178-87.
Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.
Dauerman HL, Reardon MJ, Popma JJ, Little SH, Cavalcante JL, Adams DH, Kleiman NS, Oh JK
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2016 06; 9(6).
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement.
Little SH, Oh JK, Gillam L, Sengupta PP, Orsinelli DA, Cavalcante JL, Chang JD, Adams DH, Zorn GL, Pollak AW, Abdelmoneim SS, Reardon MJ, Qiao H, Popma JJ
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction. Circ Cardiovasc Interv. 2016 06; 9(6).
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
Gleason TG, Schindler JT, Adams DH, Reardon MJ, Kleiman NS, Caplan LR, Conte JV, Deeb GM, Hughes GC, Chenoweth S, Popma JJ
The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):85-96.
The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
Popma JJ, Gleason TG, Yakubov SJ, Harrison JK, Forrest JK, Maini B, Ruiz CE, Pinto DS, Costa M, Resar J, Conte J, Crestanello J, Chang Y, Oh JK, Reardon MJ, Adams DH
Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2016 07; 9(7).
Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement.
Forrest JK, Adams DH, Popma JJ, Reardon MJ, Deeb GM, Yakubov SJ, Hermiller JB, Huang J, Skelding KA, Lansky A
Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials). Am J Cardiol. 2016 Aug 01; 118(3):396-402.
Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials).
CT Imaging of Bicuspid Aortic Valve Disease for TAVR. JACC Cardiovasc Imaging. 2016 10; 9(10):1159-1163.
CT Imaging of Bicuspid Aortic Valve Disease for TAVR.
Hermiller JB, Yakubov SJ, Reardon MJ, Deeb GM, Adams DH, Afilalo J, Huang J, Popma JJ
Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 07 26; 68(4):343-52.
Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.
Popma JJ, Reardon MJ, Yakubov SJ, Hermiller JB, Harrison JK, Gleason TG, Conte JV, Deeb GM, Chetcuti S, Oh JK, Boulware MJ, Huang J, Adams DH
Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation. JACC Cardiovasc Imaging. 2016 08; 9(8):973-81.
Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation.
Skelding KA, Yakubov SJ, Kleiman NS, Reardon MJ, Adams DH, Huang J, Forrest JK, Popma JJ
Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). Am J Cardiol. 2016 Aug 15; 118(4):560-6.
Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).
Residual aortic regurgitation after transcatheter aortic valve replacement under the echocardiographic microscope. J Thorac Cardiovasc Surg. 2016 09; 152(3):659-60.
Residual aortic regurgitation after transcatheter aortic valve replacement under the echocardiographic microscope.
Kleiman NS, Maini BJ, Reardon MJ, Conte J, Katz S, Rajagopal V, Kauten J, Hartman A, McKay R, Hagberg R, Huang J, Popma J
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials. Circ Cardiovasc Interv. 2016 09; 9(9).
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials.
Sotomi Y, Onuma Y, Dijkstra J, Eggermont J, Liu S, Tenekecioglu E, Zeng Y, Asano T, de Winter RJ, Popma JJ, Kozuma K, Tanabe K, Serruys PW, Kimura T
Impact of Implantation Technique and Plaque Morphology on Strut Embedment and Scaffold Expansion of Polylactide Bioresorbable Scaffold - Insights From ABSORB Japan Trial. Circ J. 2016 10 25; 80(11):2317-2326.
Impact of Implantation Technique and Plaque Morphology on Strut Embedment and Scaffold Expansion of Polylactide Bioresorbable Scaffold - Insights From ABSORB Japan Trial.
Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon JN, Collet C, de Winter RJ, Wykrzykowska JJ, Stone GW, Popma JJ, Kozuma K, Tanabe K, Serruys PW, Kimura T
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold? EuroIntervention. 2016 Oct 10; 12(8):e998-e1008.
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Igarashi K, Kozuma K, Tanabe K, Kusano H, Rapoza R, Popma JJ, Stone GW, Simonton C, Serruys PW, Kimura T
Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. EuroIntervention. 2016 Oct 20; 12(9):1090-1101.
Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial.
Successful Evolut R Valve-in-Valve Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2017 Jan; 103(1):365-366.
Successful Evolut R Valve-in-Valve Transcatheter Aortic Valve Replacement.
Muller DWM, Farivar RS, Jansz P, Bae R, Walters D, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, Shaw M, Scalia GM, Guerrero M, Pearson P, Kapadia S, Gillinov M, Pichard A, Corso P, Popma J, Chuang M, Blanke P, Leipsic J, Sorajja P
Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial. J Am Coll Cardiol. 2017 Jan 31; 69(4):381-391.
Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial.
Collet C, Onuma Y, Cavalcante R, Grundeken M, Généreux P, Popma J, Costa R, Stankovic G, Tu S, Reiber JHC, Aben JP, Lassen JF, Louvard Y, Lansky A, Serruys PW
Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club. EuroIntervention. 2017 May 15; 13(1):115-123.
Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club.
Harrison JK, Hughes GC, Reardon MJ, Stoler R, Grayburn P, Hebeler R, Liu D, Chang Y, Popma JJ
Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis. JACC Cardiovasc Interv. 2017 01 23; 10(2):168-175.
Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.
Cutlip DE, Garratt KN, Novack V, Barakat M, Meraj P, Maillard L, Erglis A, Jauhar R, Popma JJ, Stoler R, Silber S
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System. JACC Cardiovasc Interv. 2017 01 23; 10(2):160-167.
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.
Reply: TAVR: Risk Models, Mortality Scoring, and Geriatric Assessment. J Am Coll Cardiol. 2017 01 31; 69(4):470.
Reply: TAVR: Risk Models, Mortality Scoring, and Geriatric Assessment.
Reardon MJ, Kleiman NS, Adams DH, Yakubov SJ, Coselli JS, Deeb GM, O'Hair D, Gleason TG, Lee JS, Hermiller JB, Chetcuti S, Heiser J, Merhi W, Zorn GL, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Huang J, Popma JJ
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less. JAMA Cardiol. 2016 11 01; 1(8):945-949.
Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.
Sotomi Y, Onuma Y, Dijkstra J, Miyazaki Y, Kozuma K, Tanabe K, Popma JJ, de Winter RJ, Serruys PW, Kimura T
European heart journal. Cardiovascular Imaging
Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial. Eur Heart J Cardiovasc Imaging. 2018 01 01; 19(1):59-66.
Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
Lansky AJ, Messé SR, Brickman AM, Dwyer M, Bart van der Worp H, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Scala Moy C, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. Eur Heart J. 2018 05 14; 39(19):1687-1697.
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.
Dussaillant GR, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Leon MB
Intravascular ultrasound, directional coronary atherectomy, and the Optimal Atherectomy Restenosis Study (OARS). Coron Artery Dis. 1996 Apr; 7(4):294-8.
Intravascular ultrasound, directional coronary atherectomy, and the Optimal Atherectomy Restenosis Study (OARS).
Duissaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Griffin J, Leon MB
Intravascular ultrasound identification of calcified intraluminal lesions misdiagnosed as thrombi by coronary angiography. Am Heart J. 1996 Sep; 132(3):687-9.
Intravascular ultrasound identification of calcified intraluminal lesions misdiagnosed as thrombi by coronary angiography.
Mintz GS, Popma JJ, Hong MK, Pichard AD, Kent KM, Satler LF, Leon MB
Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol. 1996 Aug 14; 78(3A):18-22.
Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis.
Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
Effect of rotational atherectomy in noncalcified atherosclerotic plaque: a volumetric intravascular ultrasound study. J Am Coll Cardiol. 1996 Oct; 28(4):856-60.
Effect of rotational atherectomy in noncalcified atherosclerotic plaque: a volumetric intravascular ultrasound study.
Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996 Jul 01; 94(1):35-43.
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.
Eriksen UH, Amtorp O, Bagger JP, Emanuelsson H, Foegh M, Saunamäki KI, Schaeffer M, Thayssen P, Orskov H, Kuntz RE, Popma JJ
[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study]. Ugeskr Laeger. 1996 Nov 11; 158(46):6605-8.
[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study].
Popma JJ, Lansky AJ, Ito S, Mintz GS, Leon MB
Contemporary stent designs: technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy. Prog Cardiovasc Dis. 1996 Sep-Oct; 39(2):111-28.
Contemporary stent designs: technical considerations, complications, role of intravascular ultrasound, and anticoagulation therapy.
Abizaid A, Kornowski R, Mintz GS, Hong MK, Picahrd AD, Kent KM, Satler LF, Popma JJ, Bramwell O, Leon MB
Influence of guiding catheter selection on the measurement of coronary flow reserve. Am J Cardiol. 1997 Mar 01; 79(5):703-4.
Influence of guiding catheter selection on the measurement of coronary flow reserve.
Webb JG, Popma JJ, Lansky AJ, Carere RG, Rabinowitz A, Singer J, Dodek A
Early and late assessment of the Micro Stent PL coronary stent for restenosis and suboptimal balloon angioplasty. Am Heart J. 1997 Mar; 133(3):369-74.
Early and late assessment of the Micro Stent PL coronary stent for restenosis and suboptimal balloon angioplasty.
Simonton CA, Leon MB, Baim DS, Hinohara T, Kent KM, Bersin RM, Wilson BH, Mintz GS, Fitzgerald PJ, Yock PG, Popma JJ, Ho KK, Cutlip DE, Senerchia C, Kuntz RE
'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). Circulation. 1998 Feb 03; 97(4):332-9.
'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS).
Mintz GS, Douek P, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
Target lesion calcification in coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 1992 Nov 01; 20(5):1149-55.
Target lesion calcification in coronary artery disease: an intravascular ultrasound study.
Popma JJ, Leon MB, Mintz GS, Kent KM, Satler LF, Garrand TJ, Pichard AD
Results of coronary angioplasty using the transluminal extraction catheter. Am J Cardiol. 1992 Dec 15; 70(20):1526-32.
Results of coronary angioplasty using the transluminal extraction catheter.
Holmes DR, Lansky A, Kuntz R, Bell MR, Buchbinder M, Fortuna R, O'Shaughnessy CD, Popma J
The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions. Am J Cardiol. 2000 Nov 15; 86(10):1073-9.
The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions.
Bashore TM, Bates ER, Berger PB, Clark DA, Cusma JT, Dehmer GJ, Kern MJ, Laskey WK, O'Laughlin MP, Oesterle S, Popma JJ, O'Rourke RA, Abrams J, Bates ER, Brodie BR, Douglas PS, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Tracy CM, Waters DD, Winters WL
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001 Jun 15; 37(8):2170-214.
American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. Circulation. 2002 Sep 24; 106(13):1592-4.
A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease.
Tcheng JE, Madan M, O'Shea JC, Cohen EA, Buller CE, Lincoff AM, Popma JJ, Teirstein PS, Kitt MM, Lorenz TJ, Greenberg S, Fost N, Califf RM
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. J Interv Cardiol. 2003 Apr; 16(2):97-105.
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005 Apr 19; 45(8):1193-200.
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.
Hoffmann R, Mintz GS, Popma JJ, Satler LF, Pichard AD, Kent KM, Walsh C, Mackell P, Leon MB
Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol. 1996 Nov 01; 28(5):1134-9.
Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries.
Cospito PD, Popma JJ, Satler LF, Leon MB, Kent KM, Pichard AD
Prolonged intravenous urokinase infusion: an alternative pharmacologic approach in the treatment of thrombus-containing saphenous vein graft stenoses. Cathet Cardiovasc Diagn. 1992 Aug; 26(4):291-4.
Prolonged intravenous urokinase infusion: an alternative pharmacologic approach in the treatment of thrombus-containing saphenous vein graft stenoses.
Shiran A, Mintz GS, Waksman R, Mehran R, Abizaid A, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB
Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study. Circulation. 1998 Jul 21; 98(3):200-3.
Early lumen loss after treatment of in-stent restenosis: an intravascular ultrasound study.
Abizaid A, Mintz GS, Pichard AD, Kent KM, Satler LF, Walsh CL, Popma JJ, Leon MB
Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1998 Aug 15; 82(4):423-8.
Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty.
Clinical trials in interventional cardiology. Curr Opin Cardiol. 1999 Sep; 14(5):412-8.
Clinical trials in interventional cardiology.
Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C
The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol. 2000 Aug 24; 86(4B):6H-11H.
The comparative pathobiology of atherosclerosis and restenosis.
Kobayashi Y, Honda Y, Christie GL, Teirstein PS, Bailey SR, Brown CL, Matthews RV, De Franco AC, Schwartz RS, Goldberg S, Popma JJ, Yock PG, Fitzgerald PJ
Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial.A Stent vs. Stent Ultrasound Remodeling Evaluation. J Am Coll Cardiol. 2001 Apr; 37(5):1329-34.
Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial.A Stent vs. Stent Ultrasound Remodeling Evaluation.
Stent selection in clinical practice: Have clinical trials provided the evidence we need? Am Heart J. 2001 Sep; 142(3):378-80.
Stent selection in clinical practice: Have clinical trials provided the evidence we need?
Popma JJ, Hunninghake DB, Arad Y, Blumenthal RS, Boden WE, Selwyn AP
Roundtable discussion: therapeutic challenges and deficiencies. Am J Cardiol. 2001 Oct 18; 88(8A):42K-43K.
Roundtable discussion: therapeutic challenges and deficiencies.
Holmes DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, King SB, Lincoff AM, Tcheng JE, Chan R, Granett JR, Poland M
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2002 Sep 03; 106(10):1243-50.
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
Stone GW, Rogers C, Ramee S, White C, Kuntz RE, Popma JJ, George J, Almany S, Bailey S
Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. J Am Coll Cardiol. 2002 Nov 20; 40(10):1882-8.
Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy.
Current interventional cardiology reports
Distal Protection Devices During Percutaneous Saphenous Vein Graft Intervention: Has a New Standard of Care Been Established? Curr Interv Cardiol Rep. 2001 Nov; 3(4):275-280.
Distal Protection Devices During Percutaneous Saphenous Vein Graft Intervention: Has a New Standard of Care Been Established?
Hobson RW, Howard VJ, Roubin GS, Brott TG, Ferguson RD, Popma JJ, Graham DL, Howard G
Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004 Dec; 40(6):1106-11.
Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase.
von Birgelen C, Mintz GS, de Vrey EA, de Feyter PJ, Kimura T, Popma JJ, Nobuyoshi M, Serruys PW, Leon MB
Successful directional atherectomy of de novo coronary lesions assessed with three-dimensional intravascular ultrasound and angiographic follow-up. Am J Cardiol. 1997 Dec 15; 80(12):1540-5.
Successful directional atherectomy of de novo coronary lesions assessed with three-dimensional intravascular ultrasound and angiographic follow-up.
Gleason T, Popma J, Reardon M, Schindler J, Hagberg R, Deeb GM, Adams D, Conte J, Zorn T, Hughes GC
TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B152.
TCT-372 Subclavian Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.
Popma J, Dibu G, Hughes GC, Kodali S, George I, Oh J, Slater J, Williams M
TCT-37 Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results from the Evolut R US Pivotal Study. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B16.
TCT-37 Transcatheter Aortic Valve Replacement with a Repositionable Self-expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results from the Evolut R US Pivotal Study.
Sorajja P, Kodali S, Reardon M, Szeto W, Chetcuti S, Hermiller J, Adams D, Popma J
TCT-672 Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B271-B272.
TCT-672 Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM.
Chetcuti S, Kleiman N, Matthews R, Popma J
TCT-743 Percutaneous Coronary Intervention after Self-Expanding Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B300-B301.
TCT-743 Percutaneous Coronary Intervention after Self-Expanding Transcatheter Aortic Valve Replacement.
Popma JJ, Reardon MJ, Khabbaz K, Harrison JK, Hughes GC, Kodali S, George I, Deeb GM, Chetcuti S, Kipperman R, Brown J, Qiao H, Slater J, Williams MR
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study. JACC Cardiovasc Interv. 2017 02 13; 10(3):268-275.
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.
Shavelle D, Kapasi N, Banerjee S, Schreiber T, O'Neill W, Popma J, Matthews R
TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B51.
TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry.
Hermiller J, Moainie S, Yakubov S, Reardon M, Chetcuti S, Deeb GM, Harrison JK, Popma J, Moore J
TCT-35 Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results from the CoreValve US Trial Program. J Am Coll Cardiol. 2016 Nov 01; 68(18S):B14-B15.
TCT-35 Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results from the CoreValve US Trial Program.
Lansky AJ, Messé SR, Brickman AM, Dwyer M, van der Worp HB, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Moy CS, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A
Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. J Am Coll Cardiol. 2017 Feb 14; 69(6):679-691.
von Birgelen C, Mintz GS, de Vrey EA, Serruys PW, Kimura T, Nobuyoshi M, Popma JJ, Leon MB, Erbel R, de Feyter PJ
Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound. Heart. 2000 Feb; 83(2):192-7.
Preintervention lesion remodelling affects operative mechanisms of balloon optimised directional coronary atherectomy procedures: a volumetric study with three dimensional intravascular ultrasound.
Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ, Baim DS, Popma JJ, Kuntz RE, Cohen DJ
Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol. 2000 Sep 01; 86(5):485-9.
Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting.
Kornowski R, Mehran R, Hong MK, Satler LF, Pichard AD, Kent KM, Mintz GS, Waksman R, Laird JR, Lansky AJ, Bucher TA, Popma JJ, Leon MB
Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation. 1998 Apr 14; 97(14):1355-61.
Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions.
Sotomi Y, Onuma Y, Miyazaki Y, Asano T, Katagiri Y, Tenekecioglu E, Jonker H, Dijkstra J, de Winter RJ, Wykrzykowska JJ, Stone GW, Popma JJ, Kozuma K, Tanabe K, Serruys PW, Kimura T
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent? EuroIntervention. 2017 Aug 04; 13(5):e585-e594.
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Gaudiani V, Deeb GM, Popma JJ, Adams DH, Gleason TG, Conte JV, Zorn GL, Hermiller JB, Chetcuti S, Mumtaz M, Yakubov SJ, Kleiman NS, Huang J, Reardon MJ
Causes of death from the randomized CoreValve US Pivotal High-Risk Trial. J Thorac Cardiovasc Surg. 2017 06; 153(6):1293-1301.e1.
Causes of death from the randomized CoreValve US Pivotal High-Risk Trial.
O'Hair DP, Bajwa TK, Chetcuti SJ, Deeb GM, Stoler RC, Hebeler RF, Maini B, Mumtaz M, Kleiman NS, Reardon MJ, Li S, Adams DH, Watson DR, Yakubov SJ, Popma JJ, Petrossian G
One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease. Ann Thorac Surg. 2017 May; 103(5):1392-1398.
One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.
Oesterle SN, Bittl JA, Leon MB, Hamburger J, Tcheng JE, Litvack F, Margolis J, Gilmore P, Madsen R, Holmes D, Moses J, Cohen H, King S, Brinker J, Hale T, Geraci DJ, Kerker WJ, Popma J
Laser wire for crossing chronic total occlusions: "learning phase" results from the U.S. TOTAL trial. Total Occlusion Trial With Angioplasty by Using a Laser Wire. Cathet Cardiovasc Diagn. 1998 Jun; 44(2):235-43.
Laser wire for crossing chronic total occlusions: "learning phase" results from the U.S. TOTAL trial. Total Occlusion Trial With Angioplasty by Using a Laser Wire.
de Vrey EA, Mintz GS, von Birgelen C, Kimura T, Noboyoshi M, Popma JJ, Serruys PW, Leon MB
Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy. J Am Coll Cardiol. 1998 Dec; 32(7):1874-80.
Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy.
Hong MK, Mintz GS, Hong MK, Pichard AD, Satler LF, Kent KM, Popma JJ, Leon MB
Intravascular ultrasound predictors of target lesion revascularization after stenting of protected left main coronary artery stenoses. Am J Cardiol. 1999 Jan 15; 83(2):175-9.
Intravascular ultrasound predictors of target lesion revascularization after stenting of protected left main coronary artery stenoses.
Kaneda H, Ako J, Honda Y, Terashima M, Morino Y, Yock PG, Popma JJ, Leon MB, Moses JW, Fitzgerald PJ
Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation. Am J Cardiol. 2005 Nov 15; 96(10):1404-7.
Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation.
Jonas M, Stone GW, Mehran R, Hermiller J, Feldman R, Herrmann HC, Cox DA, Kuntz RE, Popma JJ, Rogers C
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection. Eur Heart J. 2006 Apr; 27(8):920-8.
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection.
Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006 Mar 15; 295(11):1253-63.
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
Mintz GS, Kent KM, Pichard AD, Popma JJ, Satler LF, Leon MB
Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis. Cardiol Clin. 1997 Feb; 15(1):17-29.
Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis.
Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation. 1997 Apr 01; 95(7):1791-8.
Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study.
Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 1998 Sep; 32(3):584-9.
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, Adams DH, Deeb GM, Maini B, Gada H, Chetcuti S, Gleason T, Heiser J, Lange R, Merhi W, Oh JK, Olsen PS, Piazza N, Williams M, Windecker S, Yakubov SJ, Grube E, Makkar R, Lee JS, Conte J, Vang E, Nguyen H, Chang Y, Mugglin AS, Serruys PW, Kappetein AP
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017 04 06; 376(14):1321-1331.
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
Baim DS, Cutlip DE, O'Shaughnessy CD, Hermiller JB, Kereiakes DJ, Giambartolomei A, Katz S, Lansky AJ, Fitzpatrick M, Popma JJ, Ho KK, Leon MB, Kuntz RE
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001 Jan 15; 87(2):152-6.
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries.
Schryver TE, Popma JJ, Kent KM, Leon MB, Eldredge S, Mintz GS
Use of intracoronary ultrasound to identify the "true" coronary lumen in chronic coronary dissection treated with intracoronary stenting. Am J Cardiol. 1992 Apr 15; 69(12):1107-8.
Use of intracoronary ultrasound to identify the "true" coronary lumen in chronic coronary dissection treated with intracoronary stenting.
Baim DS, Flatley M, Caputo R, O'Shaughnessy C, Low R, Fanelli C, Popma J, Fitzgerald P, Kuntz R
Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial). Am J Cardiol. 2001 Dec 15; 88(12):1364-9.
Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial).
Popma JJ, Weiner B, Cowley MJ, Simonton C, McCormick D, Feldman T
FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations. J Interv Cardiol. 2007 Dec; 20(6):425-46.
FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations.
Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. J Am Coll Cardiol. 2009 Oct 20; 54(17):1576-88.
Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.
Doi H, Maehara A, Mintz GS, Weissman NJ, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Stone GW
Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trials. Circ Cardiovasc Interv. 2008 Oct; 1(2):111-8.
Impact of in-stent minimal lumen area at 9 months poststent implantation on 3-year target lesion revascularization-free survival: a serial intravascular ultrasound analysis from the TAXUS IV, V, and VI trials.
Dixon SR, Whitbourn RJ, Dae MW, Grube E, Sherman W, Schaer GL, Jenkins JS, Baim DS, Gibbons RJ, Kuntz RE, Popma JJ, Nguyen TT, O'Neill WW
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 04; 40(11):1928-34.
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction.
Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, de Feyter P, Vos J, Foley DP, Ligthart JM, Popma JJ, Serruys PW
Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol. 2003 Jan 15; 41(2):184-9.
Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience.
Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CM
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. Am J Cardiol. 2005 Feb 01; 95(3):383-6.
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.
Kimura T, Kaburagi S, Tamura T, Yokoi H, Nakagawa Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M, Mintz GS, Popma JJ, Leon MB
Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation. 1997 Jul 15; 96(2):475-83.
Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy.
Heller LI, Cates C, Popma J, Deckelbaum LI, Joye JD, Dahlberg ST, Villegas BJ, Arnold A, Kipperman R, Grinstead WC, Balcom S, Ma Y, Cleman M, Steingart RM, Leppo JA
Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group. Circulation. 1997 Jul 15; 96(2):484-90.
Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group.
von Birgelen C, Mintz GS, de Vrey EA, Kimura T, Popma JJ, Airiian SG, Leon MB, Nobuyoshi M, Serruys PW, de Feyter PJ
Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes: observations with three dimensional intravascular ultrasound in vivo. Heart. 1998 Feb; 79(2):137-42.
Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes: observations with three dimensional intravascular ultrasound in vivo.
de Jaegere PP, Eefting FD, Popma JJ, Serruys PW
Seminars in interventional cardiology : SIIC
Clinical trials on intracoronary stenting. Semin Interv Cardiol. 1996 Dec; 1(4):233-45.
Clinical trials on intracoronary stenting.
Leon MB, Popma JJ, Mintz GS, Pichard AD, Satler LF, Kent KM
An overview of US coronary stent trials. Semin Interv Cardiol. 1996 Dec; 1(4):247-54.
An overview of US coronary stent trials.
Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv. 2001 Apr; 52(4):425-32.
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban.
Popma JJ, Topol EJ, Hinohara T, Pinkerton CA, Baim DS, King SB, Holmes DR, Whitlow PL, Kereiakes DJ, Hartzler GO
Abrupt vessel closure after directional coronary atherectomy. The U.S. Directional Atherectomy Investigator Group. J Am Coll Cardiol. 1992 Jun; 19(7):1372-9.
Abrupt vessel closure after directional coronary atherectomy. The U.S. Directional Atherectomy Investigator Group.
Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002 Aug 27; 106(9):1090-6.
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
Degertekin M, Serruys PW, Foley DP, Tanabe K, Regar E, Vos J, Smits PC, van der Giessen WJ, van den Brand M, de Feyter P, Popma JJ
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation. 2002 Sep 24; 106(13):1610-3.
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003 Jan; 145(1):42-6.
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.
Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, Centemero M, Maldonado G, Abizaid AS, Pinto I, Falotico R, Jaeger J, Popma JJ, Serruys PW
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2003 Jan 07; 107(1):24-7.
Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
Case presentations and discussions. J Invasive Cardiol. 2003 Mar; 15 Suppl B:34B-41B.
Feldman CL, Coskun AU, Yeghiazarians Y, Kinlay S, Wahle A, Olszewski ME, Rossen JD, Sonka M, Popma JJ, Orav J, Kuntz RE, Stone PH
Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery. Am J Cardiol. 2006 Jan 01; 97(1):13-6.
Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery.
Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME
Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005 Nov 22; 112(21):3306-13.
Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Blanke P, Park JK, Grayburn P, Naoum C, Ong K, Kohli K, Norgaard BL, Webb JG, Popma J, Boshell D, Sorajja P, Muller D, Leipsic J
Journal of cardiovascular computed tomography
Left ventricular access point determination for a coaxial approach to the mitral annular landing zone in transcatheter mitral valve replacement. J Cardiovasc Comput Tomogr. 2017 Jul - Aug; 11(4):281-287.
Left ventricular access point determination for a coaxial approach to the mitral annular landing zone in transcatheter mitral valve replacement.
Intracoronary stents: clinical and angiographic results. Herz. 1990 Oct; 15(5):307-18.
Intracoronary stents: clinical and angiographic results.
Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996 Sep 15; 94(6):1247-54.
Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study.
Baim DS, Cutlip D, Ho KK, Popma JJ, Senerchia C, Kuntz RE
Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phase. Coron Artery Dis. 1996 Apr; 7(4):290-3.
Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phase.
Kornowski R, Mintz GS, Lansky AJ, Hong MK, Kent KM, Pichard AD, Satler LF, Popma JJ, Bucher TA, Leon MB
Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol. 1998 Jun 01; 81(11):1298-304.
Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients.
Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P
International journal of radiation oncology, biology, physics
A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1097-104.
A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial.
Cutlip DE, Leon MB, Ho KK, Gordon PC, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Fitzpatrick MM, Desjardin A, Popma JJ, Kuntz RE, Baim DS
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. J Am Coll Cardiol. 1999 Sep; 34(3):698-706.
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry.
Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation. 2001 Jun 19; 103(24):3019-41.
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions.
Resnic FS, Ohno-Machado L, Selwyn A, Simon DI, Popma JJ
Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol. 2001 Jul 01; 88(1):5-9.
Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention.
Suntharalingam M, Laskey W, Lansky AJ, Waksman R, White L, Teirstien P, Massullo V, Rutherford B, Elman A, Kuntz RE, Popma JJ, Bonan R
Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):1075-82.
Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry.
Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong C, Brahimi A, Bucher T, Leon MB
Safety and efficacy of elective stent implantation following rotational atherectomy in large calcified coronary arteries. Cathet Cardiovasc Diagn. 1996; Suppl 3:50-4.
Safety and efficacy of elective stent implantation following rotational atherectomy in large calcified coronary arteries.
Silva JA, White CJ, Ramee SR, Collins TJ, Jenkins JS, Ho K, Baim DS, Carrozza JP, Rinfret S, Setum CM, Popma JJ, Kuntz RE
Treatment of coronary stent thrombosis with rheolytic thrombectomy: results from a multicenter experience. Catheter Cardiovasc Interv. 2003 Jan; 58(1):11-7.
Treatment of coronary stent thrombosis with rheolytic thrombectomy: results from a multicenter experience.
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep; 126(3 Suppl):576S-599S.
Fischell TA, Maheshwari A, Mirza RA, Haller S, Carter AJ, Popma JJ
Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting. Catheter Cardiovasc Interv. 2005 Apr; 64(4):460-7.
Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting.
Silva JA, Ramee SR, Cohen DJ, Carrozza JP, Popma JJ, Lansky AA, Dandreo K, Baim DS, George BS, McCormick DJ, Setum CM, Kuntz RE
Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. Am Heart J. 2001 Mar; 141(3):353-9.
Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002 Mar 19; 105(11):1285-90.
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
Mintz GS, Hoffmann R, Mehran R, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
In-stent restenosis: the Washington Hospital Center experience. Am J Cardiol. 1998 Apr 09; 81(7A):7E-13E.
In-stent restenosis: the Washington Hospital Center experience.
Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results. J Invasive Cardiol. 1994; 6 Suppl A:19A-28A; discussion 45A-50A.
Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
Use of enoxaparin in a patient with unstable angina. J Invasive Cardiol. 2000; 12 Suppl C:18C-20C.
Use of enoxaparin in a patient with unstable angina.
Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ
2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: American College of Cardiology Foundation Task Force on expert consensus documents Society of Thoracic Surgeons Society for Vascular Medicine. Catheter Cardiovasc Interv. 2012 Sep 01; 80(3):E37-49.
2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: American College of Cardiology Foundation Task Force on expert consensus documents Society of Thoracic Surgeons Society for Vascular Medicine.
Baim DS, Leon MB, Popma JJ, Kuntz RE, Safian RD, Desvigne Nickens P, Detre KM
Problems in the evaluation of new devices for coronary intervention: what have we learned since 1989? Am J Cardiol. 1997 Nov 20; 80(10A):3K-9K.
Problems in the evaluation of new devices for coronary intervention: what have we learned since 1989?
Carrozza JP, Schatz RA, George CJ, Leon MB, King SB, Hirshfeld JW, Curry RC, Ivanhoe RJ, Buchbinder M, Cleman MW, Goldberg S, Ricci D, Popma JJ, Safian RD, Baim DS
Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 1997 Nov 20; 80(10A):78K-88K.
Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) registry.
Mintz GS, Kovach JA, Pichard AD, Kent KM, Popma JJ, Satler LF, Griffin J, Leon MB
Intravascular ultrasound findings after excimer laser coronary angioplasty. Cathet Cardiovasc Diagn. 1996 Feb; 37(2):113-8.
Intravascular ultrasound findings after excimer laser coronary angioplasty.
Davidson CJ, Laskey WK, Hermiller JB, Harrison JK, Matthai W, Vlietstra RE, Brinker JA, Kereiakes DJ, Muhlestein JB, Lansky A, Popma JJ, Buchbinder M, Hirshfeld JW
Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation. 2000 May 09; 101(18):2172-7.
Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA
Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003 Aug 05; 108(5):548-53.
Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 02; 349(14):1315-23.
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
Beta emitter systems and results from clinical trials. state of the art. Cardiovasc Radiat Med. 2003 Apr-Jun; 4(2):54-63.
Beta emitter systems and results from clinical trials. state of the art.
Degertekin M, Lemos PA, Lee CH, Tanabe K, Sousa JE, Abizaid A, Regar E, Sianos G, van der Giessen WJ, de Feyter PJ, Wuelfert E, Popma JJ, Serruys PW
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions. Eur Heart J. 2004 Jan; 25(1):32-8.
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions.
Mauri L, O'Malley AJ, Popma JJ, Moses JW, Leon MB, Holmes DR, Teirstein PS, Cutlip DE, Donahoe D, Kuntz RE
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005 May 15; 95(10):1140-5.
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, Mehran R, Collins M, Leon MB, Popma JJ, Russell ME, Stone GW
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol. 2005 Nov 01; 96(9):1242-7.
Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study).
Stewart RE, Schwaiger M, Molina E, Popma J, Gacioch GM, Kalus M, Squicciarini S, al-Aouar ZR, Schork A, Kuhl DE
Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. Am J Cardiol. 1991 Jun 15; 67(16):1303-10.
Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease.
Abizaid A, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
Is intravascular ultrasound clinically useful or is it just a research tool? Heart. 1997 Oct; 78 Suppl 2:27-30.
Is intravascular ultrasound clinically useful or is it just a research tool?
Moses JW, Moussa I, Popma JJ, Sketch MH, Yeh W
Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions. Catheter Cardiovasc Interv. 1999 Jun; 47(2):149-54.
Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions.
Lehmann KG, Popma JJ, Werner JA, Lansky AJ, Wilensky RL
Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans. J Am Coll Cardiol. 2000 Mar 01; 35(3):583-91.
Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans.
Kop WJ, Krantz DS, Howell RH, Ferguson MA, Papademetriou V, Lu D, Popma JJ, Quigley JF, Vernalis M, Gottdiener JS
Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses. J Am Coll Cardiol. 2001 Apr; 37(5):1359-66.
Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses.
Casserly IP, Aronow HD, Schoenhagen P, Tsutsui H, Popovich J, Goormastic M, Popma JJ, Nissen SE, Tuzcu EM
Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy. J Am Coll Cardiol. 2002 Nov 06; 40(9):1573-8.
Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy.
Ansel GM, Jaff MR, Popma JJ, Battisti AJ, Lottes AE, Harnish P, Dake MD
A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease. J Endovasc Ther. 2017 Aug; 24(4):499-503.
A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease.
Deeb GM, Chetcuti SJ, Reardon MJ, Patel HJ, Grossman PM, Schreiber T, Forrest JK, Bajwa TK, O'Hair DP, Petrossian G, Robinson N, Katz S, Hartman A, Dauerman HL, Schmoker J, Khabbaz K, Watson DR, Yakubov SJ, Oh JK, Li S, Kleiman NS, Adams DH, Popma JJ
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC Cardiovasc Interv. 2017 05 22; 10(10):1034-1044.
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
Hoffmann R, Mintz GS, Kent KM, Satler LF, Pichard AD, Popma JJ, Leon MB
Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents. Am J Cardiol. 1997 Apr 01; 79(7):951-3.
Serial intravascular ultrasound predictors of restenosis at the margins of Palmaz-Schatz stents.
Blankenship JC, Mishkel GJ, Chambers CE, Hodgson JM, Holmes DR, Sheldon W, Schweiger MJ, Cowley MJ, Popma JJ
Ad hoc coronary intervention. Catheter Cardiovasc Interv. 2000 Feb; 49(2):130-4.
Dauerman HL, Prpic R, Andreou C, Popma JJ
Resolution of coronary thrombus with rescue stenting. Am J Cardiol. 2000 May 15; 85(10):1244-7.
Resolution of coronary thrombus with rescue stenting.
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation. 2006 Dec 19; 114(25):2871-91.
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.
JACC White Papers: an avenue for interventional knowledge? JACC Cardiovasc Interv. 2009 May; 2(5):472-3.
JACC White Papers: an avenue for interventional knowledge?
Popma JJ, Smitherman TC, Bedotto JB, Eichhorn EJ, Said SI, Dehmer GJ
Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide. J Cardiovasc Pharmacol. 1990 Dec; 16(6):1000-6.
Direct coronary vasodilation induced by intracoronary vasoactive intestinal peptide.
Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M, Hassan AH, Leon MB, Moses JW, Popma JJ, Bonneau HN, Yock PG, Fitzgerald PJ, Honda Y
Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol. 2005 Nov 01; 96(9):1251-3.
Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial).
Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989 Dec 07; 321(23):1557-62.
Cocaine-induced coronary-artery vasoconstriction.
Leon MB, Kandzari DE, Eisenstein EL, Anstrom KJ, Mauri L, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, Kirtane AJ, McLaurin BT, Solomon SL, Douglas JS, Popma JJ
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2009 Dec; 2(12):1208-18.
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Leon MB, Mauri L, Popma JJ, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS, Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM, Kirtane AJ, Fitzgerald PJ, Thompson K, Kandzari DE
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol. 2010 Feb 09; 55(6):543-54.
A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.
O'Rourke RA, Hochman JS, Cohen MC, Lucore CL, Popma JJ, Cannon CP
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction. Arch Intern Med. 2001 Mar 12; 161(5):674-82.
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction.
Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction. Am J Cardiol. 2001 Oct 18; 88(8A):25K-29K.
Use of coronary revascularization in patients with unstable and non-ST-segment elevation acute myocardial infarction.
Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P, Teirstein PS
Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation. 2002 Jun 11; 105(23):2737-40.
Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial.
Popma JJ, Leon MB, Moses JW, Holmes DR, Cox N, Fitzpatrick M, Douglas J, Lambert C, Mooney M, Yakubov S, Kuntz RE
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 2004 Dec 21; 110(25):3773-80.
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
Coronary Revascularization in Patients with Acute Coronary Syndromes [Record Supplied By Publisher]. J Invasive Cardiol. 1998; 10(Suppl D):22D-29D.
Coronary Revascularization in Patients with Acute Coronary Syndromes [Record Supplied By Publisher]
Jeremias A, Baim DS, Ho KK, Chauhan M, Carrozza JP, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol. 2004 Sep 15; 44(6):1210-4.
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
Massullo V, Teirstein PS, Jani S, Russo RJ, Guarneri EM, Jin H, Schatz RA, Morris NB, Steuterman S, Popma JJ, Mintz GS, Leon MB, Tripuraneni P
Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the SCRIPPS Coronary Radiation to Inhibit Proliferation Post Stenting trial. Int J Radiat Oncol Biol Phys. 1996 Nov 01; 36(4):973-5.
Endovascular brachytherapy to inhibit coronary artery restenosis: an introduction to the SCRIPPS Coronary Radiation to Inhibit Proliferation Post Stenting trial.
Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB
Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 1997 Mar 18; 95(6):1366-9.
Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study.
Coronary angioplasty of a posterolateral branch with severe proximal vessel tortuosity. Cathet Cardiovasc Diagn. 1997 Aug; 41(4):426-9.
Coronary angioplasty of a posterolateral branch with severe proximal vessel tortuosity.
Lansky AJ, Popma JJ, Mintz GS, Laird JR, Saucedo JF, Leon MB
Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective. Am J Cardiol. 1998 Apr 09; 81(7A):55E-62E.
Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective.
Hoffmann R, Mintz GS, Popma JJ, Satler LF, Kent KM, Pichard AD, Leon MB
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J. 1998 Aug; 19(8):1224-31.
Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study.
Moses JW, Weisz G, Mishkel G, Caputo R, O'shaughnessey C, Wong SC, Fischell TA, Mooney M, Williams DO, Popma JJ, Fitzgerald P, Smith S, Kuntz RE, Collins M, Cohen SA, Leon MB
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions. Catheter Cardiovasc Interv. 2007 Oct 01; 70(4):505-12.
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Cigarroa RG, Lange RA, Popma JJ, Yurow G, Sills MN, Firth BG, Hillis LD
Ethanol-induced coronary vasodilation in patients with and without coronary artery disease. Am Heart J. 1990 Feb; 119(2 Pt 1):254-9.
Ethanol-induced coronary vasodilation in patients with and without coronary artery disease.
Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J. 2008 Jul; 29(13):1625-34.
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Stone PH, Coskun AU, Kinlay S, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Yeghiazarians Y, Popma JJ, Orav J, Kuntz RE, Feldman CL
Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation. 2003 Jul 29; 108(4):438-44.
Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study.
Moses JW, Nikolsky E, Mehran R, Cambier PA, Bachinsky WB, Leya F, Kuntz RE, Popma JJ, Schleckser P, Wang H, Cohen SA, Leon MB
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. Am J Cardiol. 2006 Dec 01; 98(11):1455-60.
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
Garcia LA, Rosenfield KR, Metzger CD, Zidar F, Pershad A, Popma JJ, Zaugg M, Jaff MR
SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1259-1267.
SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.
Overestimation of acute lumen gain and late lumen loss by quantitative coronary angiography (compared with intravascular ultrasound) in stented lesions. Am J Cardiol. 1997 Nov 15; 80(10):1277-81.
Overestimation of acute lumen gain and late lumen loss by quantitative coronary angiography (compared with intravascular ultrasound) in stented lesions.
Robertson T, Kennard ED, Mehta S, Popma JJ, Carrozza JP, King SB, Holmes DR, Cowley MJ, Hornung CA, Kent KM, Roubin GS, Litvack F, Moses JW, Safian R, Desvigne-Nickens P, Detre KM
Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 1997 Nov 20; 80(10A):26K-39K.
Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry.
Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM
Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998 Feb; 31(2):241-51.
Myonecrosis after revascularization procedures.
Stone GW, Brodie BR, Griffin JJ, Costantini C, Morice MC, St Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O'Neill WW, Grines CL
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation. 1999 Mar 30; 99(12):1548-54.
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial.
Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization. Haemostasis. 1999 Dec; 29 Suppl S1:69-71.
Use of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing coronary revascularization.
Peterson ED, Lansky AJ, Anstrom KJ, Muhlbaier LH, Popma JJ, Satler LF, Lanzilotta MJ
Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. Am Heart J. 2000 Feb; 139(2 Pt 1):198-207.
Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database.
Development and evaluation of models to predict death and myocardial infarction following coronary angioplasty and stenting. Proc AMIA Symp. 2000; 690-3.
Development and evaluation of models to predict death and myocardial infarction following coronary angioplasty and stenting.
Popma JJ, Cooke RH, Leon MB, Stark K, Satler LF, Kent KM, Hunn D, Pichard AD
Immediate procedural and long-term clinical results of internal mammary artery angioplasty. Am J Cardiol. 1992 May 01; 69(14):1237-9.
Immediate procedural and long-term clinical results of internal mammary artery angioplasty.
Steinhubl SR, Talley JD, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, Navetta FI, Berger PB, Popma JJ, Dangas G, Gallo R, Sane DC, Saucedo JF, Jia G, Lincoff AM, Theroux P, Holmes DR, Teirstein PS, Kereiakes DJ
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation. 2001 May 29; 103(21):2572-8.
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study.
Weissman NJ, Wilensky RL, Tanguay JF, Bartorelli AL, Moses J, Williams DO, Bailey S, Martin JL, Canos MR, Rudra H, Popma JJ, Leon MB, Kaplan AV, Mintz GS
Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol. 2001 Aug 01; 88(3):248-52.
Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population.
Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol. 2009 Sep 01; 54(10):894-902.
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Schultheiss HP, Grube E, Kuck KH, Suttorp MJ, Heuer H, Bonnier H, Popma JJ, Kuntz RE, Fajadet J, Wijns W
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry. EuroIntervention. 2007 May; 3(1):76-81.
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry.
Spirit First - Another hurdle is cleared. EuroIntervention. 2005 Nov; 1(3):260-3.
Spirit First - Another hurdle is cleared.
Conclusion: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy. J Invasive Cardiol. 2008 Aug; 20(8 Suppl A):25A.
Conclusion: Novel approaches to managing bradycardia during coronary rheolytic thrombectomy.
Hill MD, Brooks W, Mackey A, Clark WM, Meschia JF, Morrish WF, Mohr JP, Rhodes JD, Popma JJ, Lal BK, Longbottom ME, Voeks JH, Howard G, Brott TG
Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation. 2012 Dec 18; 126(25):3054-61.
Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).
Liu J, Maehara A, Mintz GS, Weissman NJ, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Stone GW
An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J Cardiol. 2009 Feb 15; 103(4):501-6.
An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents.
Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008 Dec; 1(6):699-709.
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
Kandzari DE, Zankar AA, Teirstein PS, Brilakis ES, Banerjee S, Price MJ, Stinis CT, Hudson PA, Dahle TG, Eng M, Brown R, Ferguson A, Addo TA, Popma JJ
Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter. Catheter Cardiovasc Interv. 2011 Mar 01; 77(4):510-4.
Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter.
Stone GW, Ellis SG, Colombo A, Grube E, Popma JJ, Uchida T, Bleuit JS, Dawkins KD, Russell ME
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. JACC Cardiovasc Interv. 2011 May; 4(5):530-42.
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program.
Kandzari DE, Mauri L, Popma JJ, Turco MA, Gurbel PA, Fitzgerald PJ, Leon MB
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv. 2011 May; 4(5):543-50.
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Baim DS, Cutlip DE, Midei M, Linnemeier TJ, Schreiber T, Cox D, Kereiakes D, Popma JJ, Robertson L, Prince R, Lansky AJ, Ho KK, Kuntz RE
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001 Jan 15;87(2):157-62. 2001; 87(2):157-62.
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries
Kereiakes DJ, Waksman R, Mehra A, Morales CE, Magorien R, Mazzoni M, Popma JJ
Multicenter experience with a novel Ir-192 vascular brachytherapy device for in-stent restenosis: Final results of the Angiorad radiation therapy for in-stent restenosis intracoronaries II (ARTISTIC II) Trial. J Am Coll Cardiol. 2003; 41(6):49A.
Multicenter experience with a novel Ir-192 vascular brachytherapy device for in-stent restenosis: Final results of the Angiorad radiation therapy for in-stent restenosis intracoronaries II (ARTISTIC II) Trial
Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C
The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007 Oct 09; 50(15):1442-9.
The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial.
Suntharalingam M, Laskey WK, Tantibhedhyangkul W, Lansky A, Teirstein P, Bass T, Silber S, Rutherford B, Wilmer C, Popma JJ, Kuntz R, Bonan R
Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):536-42.
Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.
Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE, Feldman CL
Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol. 2003 Nov; 18(6):458-70.
Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior.
Stankovic G, Colombo A, Bersin R, Popma J, Sharma S, Cannon LA, Gordon P, Nukta D, Braden G, Collins M
Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. Am J Cardiol. 2004 Apr 15; 93(8):953-8.
Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing.
Baim DS, Braden G, Heuser R, Popma JJ, Cutlip DE, Massaro JM, Marulkar S, Arvay LJ, Kuntz RE
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study). Am J Cardiol. 2004 Oct 01; 94(7):853-8.
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study).
Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AG
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005 May 10; 111(18):2326-9.
Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005 Sep 14; 294(10):1215-23.
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
Kwok OH, Chow WH, Law TC, Chiu A, Ng W, Lam WF, Hong MK, Popma JJ
First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheter Cardiovasc Interv. 2005 Dec; 66(4):541-6.
First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
Surgical or Transcatheter Aortic-Valve Replacement. N Engl J Med. 2017 07 13; 377(2):197-198.
Surgical or Transcatheter Aortic-Valve Replacement.
Afilalo J, Lauck S, Kim DH, Lefèvre T, Piazza N, Lachapelle K, Martucci G, Lamy A, Labinaz M, Peterson MD, Arora RC, Noiseux N, Rassi A, Palacios IF, Généreux P, Lindman BR, Asgar AW, Kim CA, Trnkus A, Morais JA, Langlois Y, Rudski LG, Morin JF, Popma JJ, Webb JG, Perrault LP
Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol. 2017 Aug 08; 70(6):689-700.
Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.
Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol. 1995 Jun; 25(7):1479-85.
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations.
Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, Ditrano CJ, Leon MB
Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation. 1995 Apr 01; 91(7):1959-65.
Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions.
Schampaert E, Moses JW, Schofer J, Schlüter M, Gershlick AH, Cohen EA, Palisaitis DA, Breithardt G, Donohoe DJ, Wang H, Popma JJ, Kuntz RE, Leon MB
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. Am J Cardiol. 2006 Jul 01; 98(1):36-41.
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
Gershlick A, Kandzari DE, Leon MB, Wijns W, Meredith IT, Fajadet J, Popma JJ, Fitzgerald PJ, Kuntz RE
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients. Am J Cardiol. 2007 Oct 22; 100(8B):45M-55M.
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008 Feb 12; 117(6):790-7.
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
Popma JJ, Smitherman TC, Walker BS, Simon TR, Dehmer GJ
Reverse redistribution of thallium-201 detected by SPECT imaging after dipyridamole in angina pectoris. Am J Cardiol. 1990 May 15; 65(18):1176-80.
Reverse redistribution of thallium-201 detected by SPECT imaging after dipyridamole in angina pectoris.
Hong MK, Wong SC, Popma JJ, Kent KM, Pichard AD, Satler LF, Mintz GS, Nikonow K, Leon MB
A dual-purpose angioplasty-drug infusion catheter for the treatment of intragraft thrombus. Cathet Cardiovasc Diagn. 1994 Jun; 32(2):193-5.
A dual-purpose angioplasty-drug infusion catheter for the treatment of intragraft thrombus.
Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, Cremonesi A, Fairman R, Walker G, Verta P, Popma J, Virmani R, Cohen DJ
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg. 2006 Aug; 44(2):258-68.
Protected carotid stenting in high-surgical-risk patients: the ARCHeR results.
Mintz GS, Pichard AD, Popma JJ, Kent KM, Satler LF, Bucher TA, Leon MB
Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol. 1997 Feb; 29(2):268-74.
Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study.
Fishman NW, Kennard ED, Steenkiste AR, Popma JJ, Baim DS, Detre KM
New Approaches to Coronary Intervention (NACI) registry: history and methods. Am J Cardiol. 1997 Nov 20; 80(10A):10K-18K.
New Approaches to Coronary Intervention (NACI) registry: history and methods.
Hoffmann R, Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Hong MK, Laird JR, Leon MB
Comparative early and nine-month results of rotational atherectomy, stents, and the combination of both for calcified lesions in large coronary arteries. Am J Cardiol. 1998 Mar 01; 81(5):552-7.
Comparative early and nine-month results of rotational atherectomy, stents, and the combination of both for calcified lesions in large coronary arteries.
Popma JJ, Weitz J, Bittl JA, Ohman EM, Kuntz RE, Lansky AJ, King SB
Antithrombotic therapy in patients undergoing coronary angioplasty. Chest. 1998 Nov; 114(5 Suppl):728S-741S.
Cantor WJ, Peterson ED, Popma JJ, Zidar JP, Sketch MH, Tcheng JE, Ohman EM
Provisional stenting strategies: systematic overview and implications for clinical decision-making. J Am Coll Cardiol. 2000 Oct; 36(4):1142-51.
Provisional stenting strategies: systematic overview and implications for clinical decision-making.
Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006 Dec 19; 48(12):2440-7.
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Minerva Cardioangiol. 2007 Feb; 55(1):1-18.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial.
Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol. 2008 Jan 01; 51(1):23-32.
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.
Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. JACC Cardiovasc Interv. 2009 Oct; 2(10):967-76.
Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
Popma JJ, Mauri L, O'Shaughnessy C, Overlie P, McLaurin B, Almonacid A, Kirtane A, Leon MB
Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents. Circ Cardiovasc Interv. 2009 Apr; 2(2):133-9.
Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.
Smitherman TC, Popma JJ, Said SI, Krejs GJ, Dehmer GJ
Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans. Am J Physiol. 1989 Oct; 257(4 Pt 2):H1254-62.
Coronary hemodynamic effects of intravenous vasoactive intestinal peptide in humans.
Yeung AC, Leon MB, Jain A, Tolleson TR, Spriggs DJ, Mc Laurin BT, Popma JJ, Fitzgerald PJ, Cutlip DE, Massaro JM, Mauri L
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial. J Am Coll Cardiol. 2011 Apr 26; 57(17):1778-83.
Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial.
Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med. 1988 Sep 22; 319(12):733-40.
Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.
Grayburn PA, Popma JJ, Pryor SL, Walker BS, Simon TR, Smitherman TC
Limitations of dipyridamole-doppler echocardiography in the assessment of ischemia-induced alterations of left ventricular systolic and diastolic function. Am J Cardiol. 1989; 1315-1320.
Limitations of dipyridamole-doppler echocardiography in the assessment of ischemia-induced alterations of left ventricular systolic and diastolic function
Chan CK, Kinlay S, Popma JJ, Rogers C, Resnic FS
Effect of diabetes mellitus on the predictive value of myocardial fractional flow reserve. J Am Coll Cardiol. 2003; 41(6):2A.
Effect of diabetes mellitus on the predictive value of myocardial fractional flow reserve
Dave RM, Patlola R, Kollmeyer K, Bunch F, Weinstock BS, Dippel E, Jaff MR, Popma J, Weissman N
Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009 Dec; 16(6):665-75.
Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry.
Guagliumi G, Sirbu V, Musumeci G, Bezerra HG, Aprile A, Kyono H, Fiocca L, Matiashvili A, Lortkipanidze N, Vassileva A, Popma JJ, Allocco DJ, Dawkins KD, Valsecchi O, Costa MA
Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv. 2010 Aug; 3(4):367-75.
Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI).
Comparison of dipyridamole-Doppler echocardiography to thallium-201 imaging and quantitative coronary arteriography in the assessment of coronary artery disease. Am J Cardiol. 1989 Jun 01; 63(18):1315-20.
Comparison of dipyridamole-Doppler echocardiography to thallium-201 imaging and quantitative coronary arteriography in the assessment of coronary artery disease.
Matar FA, Mintz GS, Pinnow E, Javier SP, Popma JJ, Kent KM, Satler LF, Pichard AD, Leon MB
Multivariate predictors of intravascular ultrasound end points after directional coronary atherectomy. J Am Coll Cardiol. 1995 Feb; 25(2):318-24.
Multivariate predictors of intravascular ultrasound end points after directional coronary atherectomy.
Matar FA, Mintz GS, Douek P, Farb A, Virmani R, Javier SP, Popma JJ, Pichard AD, Kent KM, Satler LF
Coronary artery lumen volume measurement using three-dimensional intravascular ultrasound: validation of a new technique. Cathet Cardiovasc Diagn. 1994 Nov; 33(3):214-20.
Coronary artery lumen volume measurement using three-dimensional intravascular ultrasound: validation of a new technique.
Matar FA, Mintz GS, Farb A, Douek P, Pichard AD, Kent KM, Satler LF, Popma JJ, Keller MB, Pinnow E
The contribution of tissue removal to lumen improvement after directional coronary atherectomy. Am J Cardiol. 1994 Oct 01; 74(7):647-50.
The contribution of tissue removal to lumen improvement after directional coronary atherectomy.
Stewart RE, Popma J, Gacioch GM, Kalus M, Squicciarini S, al-Aouar Z, Schork MA, Schwaiger M
International journal of cardiac imaging
Comparison of thallium-201 SPECT redistribution patterns and rubidium-82 PET rest-stress myocardial blood flow imaging. Int J Card Imaging. 1994 Mar; 10(1):15-23.
Comparison of thallium-201 SPECT redistribution patterns and rubidium-82 PET rest-stress myocardial blood flow imaging.
Laird JR, Popma JJ, Knopf WD, Yakubov S, Satler L, White H, Bergelson B, Hennecken J, Lewis S, Parks JM, Holmes DR
Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter. Tapered Balloon Registry Investigators. Am J Cardiol. 1996 Mar 15; 77(8):561-8.
Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter. Tapered Balloon Registry Investigators.
Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998 Dec 03; 339(23):1665-71.
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
Popma JJ, Califf RM, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Stump D, Woodlief L
Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study. J Am Coll Cardiol. 1992 Nov 15; 20(6):1305-12.
Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study.
Kereiakes D, Linnemeier TJ, Baim DS, Kuntz R, O'Shaughnessy C, Hermiller J, Fink S, Lansky A, Nishimura N, Broderick TM, Popma J
Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials). Am J Cardiol. 2000 Aug 01; 86(3):336-41.
Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials).
Yahagi K, Torii S, Ladich E, Kutys R, Romero ME, Mori H, Kolodgie FD, Popma JJ, Virmani R, Finn AV
Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials. Catheter Cardiovasc Interv. 2018 04 01; 91(5):947-955.
Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
Resnic FS, Blake GJ, Ohno-Machado L, Selwyn AP, Popma JJ, Rogers C
Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol. 2001 Sep 01; 88(5):493-6.
Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors.
Heuser R, Laskey W, Lansky A, Popma J, Bonan R
Beta radiation in lesions > 15 mm: a START subgroup. J Invasive Cardiol. 2003 Nov; 15(11):641-3.
Beta radiation in lesions > 15 mm: a START subgroup.
Sawhney N, Moses JW, Leon MB, Kuntz RE, Popma JJ, Bachinsky W, Bass T, DeMaio S, Fry E, Holmes DR, Teirstein PS
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation. 2004 Jul 27; 110(4):374-9.
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J
Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol. 2006 Jul 18; 48(2):244-52.
Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):670S-707S.
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Mahmud E, Ormiston JA, Turco MA, Popma JJ, Weissman NJ, O'Shaughnessy CD, Mann T, Hall JJ, McGarry TF, Cannon LA, Webster MW, Mandinov L, Baim DS
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2009 Mar; 2(3):240-52.
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
Friedewald VE, Gibbons RJ, O'Neill WW, Popma JJ, Stone GW, Roberts WC
The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction. Am J Cardiol. 2009 Sep 15; 104(6):791-7.
The editor's roundtable: intracoronary hyperoxemic therapy in acute myocardial infarction.
Dawkins KD, Stone GW, Colombo A, Grube E, Ellis SG, Popma JJ, Serruys PW, Lam P, Koglin J, Russell ME
Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments. EuroIntervention. 2006 May; 2(1):61-8.
Integrated analysis of medically treated diabetic patients in the TAXUS(R) program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments.
Kalra A, Andalib A, Ramadan R, Hafiz AM, Poulin MF, Tamez H, Pinto DS, Popma JJ
Preparing interventional Fellows for advanced training in structural heart disease interventions. Eur Heart J. 2017 03 07; 38(10):701-703.
Preparing interventional Fellows for advanced training in structural heart disease interventions.
Weintraub WS, Grau-Sepulveda MV, Weiss JM, O'Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH
Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 Apr 19; 366(16):1467-76.
Comparative effectiveness of revascularization strategies.
Jaff MR, Bates M, Sullivan T, Popma J, Gao X, Zaugg M, Verta P
Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv. 2012 Sep 01; 80(3):343-50.
Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.
Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Teirstein PS, Kleiman NS, Hattel LJ, Anderson HV, Ferguson JJ, Cabot CF, Anderson KM, Berdan LG, Musco MH, Weisman HF, Topol EJ
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. Am J Cardiol. 1997 Feb 01; 79(3):286-91.
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.
Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y
Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions. Circ Cardiovasc Interv. 2017 Oct; 10(10).
Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions.
Waksman R, Popma JJ, Kennard ED, George CJ, Douglas JS, Cowley M, Leon MB, Holmes DR, Hinohara T, Safian RD, Hornung CA, Brinker JA, Roubin GS, Bonan R, Kereiakes D, Matthews RV, Baim DS
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 1997 Nov 20; 80(10A):50K-59K.
Directional coronary atherectomy (DCA): a report from the New Approaches to Coronary Intervention (NACI) registry.
Brown DL, George CJ, Steenkiste AR, Cowley MJ, Leon MB, Cleman MW, Moses JW, King SB, Carrozza JP, Holmes DR, Burkhard-Meier C, Popma JJ, Brinker JA, Buchbinder M
High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 1997 Nov 20; 80(10A):60K-67K.
High-speed rotational atherectomy of human coronary stenoses: acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry.
Mehran R, Mintz GS, Hong MK, Tio FO, Bramwell O, Brahimi A, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB
Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J Am Coll Cardiol. 1998 Sep; 32(3):794-9.
Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes.
O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012 Oct 02; 126(14):1717-27.
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans. J Am Coll Cardiol 2000 Mar 1;35(3):583-91. 2000; 35(3):583-91.
Doucet M, Seto TB, Lansky AJ, Leon MB, Popma JJ, Kuntz RE, Cohen DJ
Predictors of recurrent restenosis after treatment of in-stent restenosis implications for the cost-effectiveness of vascular brachytherapy. Circulation. 2001; 104(17):II-348.
Predictors of recurrent restenosis after treatment of in-stent restenosis implications for the cost-effectiveness of vascular brachytherapy
Dixon SR, Rizik DG, Griffin JJ, Carrozza JP, Rutherford BD, Kastrati A, Thambar ST, Kuntz RE, Gibbons RJ, Popma JJ, O'Neill WW
A Prospective, Randomized Trial of Mild Hypothermia During Primary Percutaneous Intervention for Acute Myocardial Infarction (COOL-MI): One-Year Clinical Outcome. J Am Coll Cardiol. 2004; in press.
A Prospective, Randomized Trial of Mild Hypothermia During Primary Percutaneous Intervention for Acute Myocardial Infarction (COOL-MI): One-Year Clinical Outcome
Antmann EM (Editor); Colucci WS, Gotto AM, Josephson ME, Loscalzo J, Oparil S, Popma JJ (Section Editors)
Cardiovascular Therapeutics. 2002; 1-1213.
Lindsay J, Pinnow EE, Popma JJ, Pichard AD
Obstacles to outcomes analysis in percutaneous transluminal coronary revascularization. Am J Cardiol. 1995 Jul 15; 76(3):168-72.
Obstacles to outcomes analysis in percutaneous transluminal coronary revascularization.
Popma JJ, Chuang YC, Satler LF, Kleiber B, Leon MB
Primary coronary angioplasty in patients with acute myocardial infarction. Tex Heart Inst J. 1994; 21(2):148-57.
Primary coronary angioplasty in patients with acute myocardial infarction.
Altmann DB, Popma JJ, Pichard AD, Kent KM, Satler LF, Keller MB, Gallino RA, Mintz GS, Leon MB
Impact of directional atherectomy on adjacent branch vessels. Am J Cardiol. 1993 Aug 01; 72(3):351-3.
Impact of directional atherectomy on adjacent branch vessels.
Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB
Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol. 1999 Jan 15; 83(2):260-3, A5.
Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency.
Ethical Issues in Interventional Cardiology. CathSAP-II Nissen SE (Editor), Popma JJ, Kern MJ (Co-Editor). 2001.
Ethical Issues in Interventional Cardiology
Treatment of fibromuscular dysplasia and renal artery aneurysm with use of a stent-graft. J Vasc Interv Radiol. 2001 Jun; 12(6):757-60.
Treatment of fibromuscular dysplasia and renal artery aneurysm with use of a stent-graft.
Cohen DJ, Doucet M, Cutlip DE, Ho KK, Popma JJ, Kuntz RE
Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation. 2001 Aug 14; 104(7):773-8.
Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?
Rizik DG, Popma JP, Leon MB, Mintz GS, Weiner B, Cohen E, Lansky AJ, Adem AM, Bouhasin AP, Wojciechowski C, Weissman NJ
Benefits of cutting balloon before stenting. J Invasive Cardiol. 2003 Nov; 15(11):624-8.
Benefits of cutting balloon before stenting.
Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C
Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol. 2004 Nov 01; 94(9):1174-7.
Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients.
Kereiakes DJ, Wang H, Popma JJ, Kuntz RE, Donohoe DJ, Schofer J, Schampaert E, Meier B, Leon MB, Moses JW
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol. 2006 Jul 04; 48(1):21-31.
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.
Jonas M, Fang JC, Wang JC, Giri S, Elian D, Har-Zahav Y, Ly H, Seifert PA, Popma JJ, Rogers C
In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. J Am Coll Cardiol. 2006 Aug 01; 48(3):453-61.
In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
Chauhan MS, Kuntz RE, Ho KL, Cohen DJ, Popma JJ, Carrozza JP, Baim DS, Cutlip DE
Coronary artery stenting in the aged. J Am Coll Cardiol. 2001 Mar 01; 37(3):856-62.
Bass TA, Gilmore P, Zenni M, Sasseen B, Savage M, Bonan R, Laskey W, Popma JJ, Costa MA
Debulking does not benefit patients undergoing intracoronary beta-radiation therapy for in-stent restenosis: insights from the START trial. Catheter Cardiovasc Interv. 2003 Mar; 58(3):331-5.
Debulking does not benefit patients undergoing intracoronary beta-radiation therapy for in-stent restenosis: insights from the START trial.
Sorajja P, Kodali S, Reardon MJ, Szeto WY, Chetcuti SJ, Hermiller J, Chenoweth S, Adams DH, Popma JJ
Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2017 10 23; 10(20):2090-2098.
Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
Goldstein JA, Dixon SR, Douglas PS, Ohman EM, Moses J, Popma JJ, O'Neill WW
Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study. Catheter Cardiovasc Interv. 2018 10 01; 92(4):813-817.
Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study.
Drug-eluting stents. Cardiol Clin. 2006 May; 24(2):217-31, vi.
Chambers CE, Dehmer GJ, Cox DA, Harrington RA, Babb JD, Popma JJ, Turco MA, Weiner BH, Tommaso CL
Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheter Cardiovasc Interv. 2009 Jun 01; 73(7):847-58.
Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation.
Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. JACC Cardiovasc Interv. 2008 Jun; 1(3):248-57.
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
"Bailing out" side branches: technique trumps technology, round 1. J Invasive Cardiol. 2009 Oct; 21(10):538.
"Bailing out" side branches: technique trumps technology, round 1.
Meredith IT, Worthley S, Whitbourn R, Walters DL, McClean D, Horrigan M, Popma JJ, Cutlip DE, DePaoli A, Negoita M, Fitzgerald PJ
Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv. 2009 Oct; 2(10):977-85.
Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial.
Higashida RT, Popma JJ, Apruzzese P, Zimetbaum P
Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials. Stroke. 2010 Feb; 41(2):e102-9.
Evaluation of the medtronic exponent self-expanding carotid stent system with the medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System with distal protection In the treatment of Carotid stenosis) I and MAVErIC II trials.
Lasala JM, Mehran R, Moses JW, Popma JJ, Reiner JS, Sharma SK, Vetrovec GW
Evidence based management of patients undergoing PCI. Conclusion. Catheter Cardiovasc Interv. 2010 Mar 01; 75 Suppl 1:S43-5.
Evidence based management of patients undergoing PCI. Conclusion.
Uchida T, Popma J, Stone GW, Ellis SG, Turco MA, Ormiston JA, Muramatsu T, Nakamura M, Nanto S, Yokoi H, Baim DS
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv. 2010 Apr; 3(4):403-11.
The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007 Sep 01; 100(5):818-23.
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).
Variability of coronary flow reserve obtained immediately after coronary angioplasty. Int J Card Imaging. 1990-1991; 6(1):31-8.
Variability of coronary flow reserve obtained immediately after coronary angioplasty.
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the Past and Standards for the Future. Catheter Cardiovasc Interv. 2010 Oct 01; 76(4):E111-25.
In vivo assessment of a digital angiographic method to measure absolute coronary artery diameters. Am J Cardiol. 1989 Jul 15; 64(3):131-8.
In vivo assessment of a digital angiographic method to measure absolute coronary artery diameters.
Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions. Circ Cardiovasc Interv. 2011 Apr 01; 4(2):146-54.
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions.
Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Tommaso CL
2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. J Am Coll Cardiol. 2012 Jun 12; 59(24):2221-305.
2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine.
Kandzari DE, Teirstein PS, Kereiakes DJ, Cannon LA, Hearne SE, Kuo HC, Ying SW, Cheong WF, Popma JJ
Procedural effectiveness of a novel 1.20?mm diameter angioplasty catheter: clinical and angiographic outcomes. J Interv Cardiol. 2013 Apr; 26(2):131-6.
Procedural effectiveness of a novel 1.20?mm diameter angioplasty catheter: clinical and angiographic outcomes.
Gleason TG, Schindler JT, Hagberg RC, Deeb GM, Adams DH, Conte JV, Zorn GL, Hughes GC, Guo J, Popma JJ, Reardon MJ
Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral. Ann Thorac Surg. 2018 Feb; 105(2):477-483.
Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.
Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial. J Am Coll Cardiol. 2017 Dec 12; 70(23):2852-2862.
3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.
Popma JJ, Cigarroa RC, Buja LM, Hillis LD
Diagnostic and prognostic utility of right heart catheterization and endomyocardial biopsy in patients with dilated cardiomyopathy. Am J Cardiol. 1989; 63:955-959.
Diagnostic and prognostic utility of right heart catheterization and endomyocardial biopsy in patients with dilated cardiomyopathy
Painter JA,Mintz GS, Wong SC, Popma JJ, Pichard AD, Kent KM, Satler LF, Leon MB
Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol 1995 Feb 15;75(5):398-400. 1995; 75(5):398-499.
Cannon L, Siegel R, Greenberg J, Rao R, Prpic R, Chan S, Popma JJ
Recanalization of total coronary occlusions using a sonicross low frequency ultrasound catheter. J Am Coll Cardiol. 2002; 35(2):41A.
Recanalization of total coronary occlusions using a sonicross low frequency ultrasound catheter
Giri S, Kuntz RE, Eisenhauer AC, Popma JJ, Prpic R, Kaya U, Rogers C, Baim DS
Effect of baseline thrombus in the SAFER (Saphenous vein graft angioplasty free of emboli randomized). J Am Coll Cardiol. 2002; 39(5):52A.
Effect of baseline thrombus in the SAFER (Saphenous vein graft angioplasty free of emboli randomized)
Prpic R, Kuntz RE, Cox N, Ho K, Fitzpatrick M, Giri S, Cutlip DE, Popma JJ
Late angiographic assessment of the edge effect and restenosis associated with intraluminal sonotherapy: Results from the SILENT (Sonotherapy for In-Lesion Elimination of Neointimal Tissue) Trial. J Am Coll Cardiol. 2002; 39(5):3A.
Late angiographic assessment of the edge effect and restenosis associated with intraluminal sonotherapy: Results from the SILENT (Sonotherapy for In-Lesion Elimination of Neointimal Tissue) Trial
Holmes, DR, Moses J, Leon M, Midei M, Mooney M, Baim D, DeMaio S, Popma J, Kuntz RE
Sirolimus Versus Plain Old Balloon Angioplasty Small Vessels. J Am Coll Cardiol. 2004; in press.
Sirolimus Versus Plain Old Balloon Angioplasty Small Vessels
Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. Circulation. 2003 Sep 16; 108(11):1310-5.
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.
Mehran R, Mintz GS, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB
Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis. Am J Cardiol. 1996 Sep 15; 78(6):618-22.
Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis.
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004 Apr 27; 109(16):1942-7.
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 Oct 07; 351(15):1493-501.
Protected carotid-artery stenting versus endarterectomy in high-risk patients.
Dick RJ, Popma JJ, Muller DW, Burek KA, Topol EJ
In-hospital costs associated with new percutaneous coronary devices. Am J Cardiol. 1991 Oct 01; 68(9):879-85.
In-hospital costs associated with new percutaneous coronary devices.
Crestanello JA, Popma JJ, Adams DH, Deeb GM, Mumtaz M, George B, Huang J, Reardon MJ
Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease. JACC Cardiovasc Interv. 2017 11 27; 10(22):2283-2293.
Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.
Ellis SG, Popma JJ, Stone GW, Russell ME
Restenosis, statistics, and reasonable inferences. J Am Coll Cardiol. 2006 Jan 17; 47(2):470-1; author reply 471.
Restenosis, statistics, and reasonable inferences.
Turco MA, Buchbinder M, Popma JJ, Weissman NJ, Mann T, Doucet S, Johnson WL, Greenberg JD, Leadley K, Russell ME
Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Catheter Cardiovasc Interv. 2006 Sep; 68(3):379-88.
Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial.
Lansky AJ, Popma JJ, Massullo V, Jani S, Russo RJ, Schatz RA, Steuterman S, Guarneri EM, Wu H, Mehran R, Mintz GS, Leon MB, Teirstein PS
Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial. Am J Cardiol. 1999 Aug 15; 84(4):410-4.
Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial.
Escolar E, Mintz GS, Popma J, Michalek A, Kim SW, Mandinov L, Koglin J, Stone G, Ellis SG, Grube E, Dawkins KD, Weissman NJ
Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). Am J Cardiol. 2007 Aug 15; 100(4):621-6.
Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI).
Giri S, Ito S, Lansky AJ, Mehran R, Margolis J, Gilmore P, Garratt KN, Cummins F, Moses J, Rentrop P, Oesterle S, Power J, Kent KM, Satler LF, Pichard AD, Wu H, Greenberg A, Bucher TA, Kerker W, Abizaid AS, Saucedo J, Leon MB, Popma JJ
Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry. Catheter Cardiovasc Interv. 2001 Jan; 52(1):24-34.
Clinical and angiographic outcome in the laser angioplasty for restenotic stents (LARS) multicenter registry.
Tanabe K, Popma JJ, Kozuma K, Saito S, Muramatsu T, Nakamura S, Namiki A, Morino Y, Hagiwara N, Uematsu M, Kawasaki T, Fujii K, Serruys PW, Onuma Y, Ying S, Kusano H, Stone GW, Kimura T
Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial. EuroIntervention. 2018 Oct 12; 14(9):e1020-e1028.
Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial.
Piana RN, Adams MR, Orford JL, Popma JJ, Adams DH, Goldhaber SZ
Rescue percutaneous coronary intervention immediately following coronary artery bypass grafting. Chest. 2001 Oct; 120(4):1417-20.
Rescue percutaneous coronary intervention immediately following coronary artery bypass grafting.
Mauri L, Reisman M, Buchbinder M, Popma JJ, Sharma SK, Cutlip DE, Ho KK, Prpic R, Zimetbaum PJ, Kuntz RE
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May; 145(5):847-54.
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART).
Ellis SG, De Cesare NB, Pinkerton CA, Whitlow P, King SB, Ghazzel ZM, Kereiakes DJ, Popma JJ, Menke KK, Topol EJ
Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy. Circulation. 1991 Aug; 84(2):644-53.
Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy.
Kereiakes DJ, Cannon LA, Feldman RL, Popma JJ, Magorien R, Whitbourn R, Dauber IM, Rabinowitz AC, Ball MW, Bertolet B, Kabour A, Foster MC, Wang JC, Underwood P, Dawkins KD
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial. J Am Coll Cardiol. 2010 Jul 20; 56(4):264-71.
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial.
Ormiston JA, Abizaid A, Spertus J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Dubois C, Hoffmann R, Wijns W, Fitzgerald PJ, Popma JJ, Macours N, Cebrian A, Stoll HP, Rogers C, Spaulding C
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. Circ Cardiovasc Interv. 2010 Dec; 3(6):556-64.
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions.
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011 Jan 18; 57(3):253-69.
O'Hair DP, Bajwa TK, Popma JJ, Watson DR, Yakubov SJ, Adams DH, Sharma S, Robinson N, Petrossian G, Caskey M, Byrne T, Kleiman NS, Zhang A, Reardon MJ
Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device. Ann Thorac Surg. 2018 Feb; 105(2):484-490.
Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device.
Conte JV, Hermiller J, Resar JR, Deeb GM, Gleason TG, Adams DH, Popma JJ, Yakubov SJ, Watson D, Guo J, Zorn GL, Reardon MJ
Seminars in thoracic and cardiovascular surgery
Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement. Semin Thorac Cardiovasc Surg. 2017 Autumn; 29(3):321-330.
Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
Levetan CS, Dawn KR, Murray JF, Popma JJ, Ratner RE, Robbins DC
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Impact of computer-generated personalized goals on cholesterol lowering. Value Health. 2005 Nov-Dec; 8(6):639-46.
Impact of computer-generated personalized goals on cholesterol lowering.
Kereiakes DJ, Popma JJ, Cannon LA, Kandzari DE, Kimmelstiel CD, Meredith IT, Teirstein PS, Verheye S, Allocco DJ, Dawkins KD, Stone GW
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials. EuroIntervention. 2012 Jun 20; 8(2):187-95.
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials.
Coronary Angiography and Intravascular Ultrasonography. Heart Disease: A Textbook of Cardiovascular Medicine (6th Edition). Braunwald E, Zipes DP, Libby P (Editors). 2001; 387-421.
Moses JW, Whitlow P, Buchbinder M, Popma JJ
AST SLK-View: A Novel Approach for Treatment of Bifurcation Lesions. J Am Coll Cardiol. 2003; in press.
AST SLK-View: A Novel Approach for Treatment of Bifurcation Lesions
Moses JW, Buller CE, Nukta ED, Aluka AO, Farhat N, Barbeau GR, Popma JJ, Moussa I, New GS, Feit F
The first clinical trial comparing a coated versus a non-coated coronary stent: The Biocompatibles BiodivYsio Stent in randomized control trial (DISTINCT). Circulation. 2000; 102(18):II-664.
The first clinical trial comparing a coated versus a non-coated coronary stent: The Biocompatibles BiodivYsio Stent in randomized control trial (DISTINCT)
Axial plaque redistribution as a mechanism of percutaneous transluminal coronary angioplasty. Am J Cardiol. 1996 Feb 15; 77(5):427-30.
Axial plaque redistribution as a mechanism of percutaneous transluminal coronary angioplasty.
Cathet Cardiovasc Diagn 1996;Suppl 3:50-4
Safety and efficacy of elective stent implantation following rotational atherectomy in large calcified coronary arteries. Cathet Cardiovasc Diagn 1996;Suppl 3:50-4. 1996; 37(Suppl 3):50-4.
Textbook of Interventional Cardiology. Topol EJ (Editor)
Qualitative and Quantitative Angiography. Textbook of Interventional Cardiology. Topol EJ (Editor). 1993.
Qualitative and Quantitative Angiography
Anagnostopoulos C, Almonacid A, El Fakhri G, Curillova Z, Sitek A, Roughton M, Dorbala S, Popma JJ, Di Carli MF
European journal of nuclear medicine and molecular imaging
Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008 Sep; 35(9):1593-601.
Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity.
Baron SJ, Arnold SV, Reynolds MR, Wang K, Deeb M, Reardon MJ, Hermiller J, Yakubov SJ, Adams DH, Popma JJ, Cohen DJ
Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial. Am Heart J. 2017 Dec; 194:39-48.
Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB
A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009 Apr 01; 103(7):923-9.
A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation.
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings assessments of the past and standards for the future. Heart Rhythm. 2010 Oct; 7(10):1522-35.
SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings assessments of the past and standards for the future.
Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, Fitzgerald PJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Schwartz LB
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. JACC Cardiovasc Interv. 2008 Oct; 1(5):524-32.
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. EuroIntervention. 2005 Aug; 1(2):157-64.
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.
George JC, Varghese V, Dangas G, Popma JJ
Transcatheter aortic valve implantation: lessons from the PARTNER (Placement of Aortic Transcatheter Valves) trial. JACC Cardiovasc Interv. 2011 Jan; 4(1):132-3.
Transcatheter aortic valve implantation: lessons from the PARTNER (Placement of Aortic Transcatheter Valves) trial.
Santangelo WC, Unger RH, Orci L, Dueno MI, Popma JJ, Krejs GJ
Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration. Pancreas. 1986; 1(5):464-9.
Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.
Kuntz RE, Moses JW, Abizaid AC, Chronos NAF, Mooney MR, Low RI, Yeung AC, Losordo DW, Carrozza JP, Weissman NJ, Popma JJ, Serruys PW
Intravascular sonotherapy in human coronary arteries: First results of a feasibility trial. J Am Coll Cardiol. 2001; 37(2):45A.
Intravascular sonotherapy in human coronary arteries: First results of a feasibility trial
Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Wong SC, Bucher T, Leon MB
Angiographic results and late clinical outcomes utilizing a stent synergy (pre-stent atheroablation) approach in complex lesion subsets. J Invasive Cardiol. 1996; 8(1):15-22.
Angiographic results and late clinical outcomes utilizing a stent synergy (pre-stent atheroablation) approach in complex lesion subsets
Hermiller JB, Ellis SG, Cannon L, Mooney M, Lui H, Midei M, Koglin J, Russell ME, PopmamJJ, Stone GW
TAXUS IV Diabetic Subset Analysis: Improvements in Nine-Month Outcomes in Diabetics on Oral Medication as Well as Insulin. J Am Coll Cardiol. 2004; in press.
TAXUS IV Diabetic Subset Analysis: Improvements in Nine-Month Outcomes in Diabetics on Oral Medication as Well as Insulin
Mintz GS, Griffin J, Chuang YC, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB
Reproducibility of the intravascular ultrasound assessment of stent implantation in saphenous vein grafts. Am J Cardiol. 1995 Jun 15; 75(17):1267-70.
Reproducibility of the intravascular ultrasound assessment of stent implantation in saphenous vein grafts.
Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Leon MB
Limitations of angiography for analyzing coronary atherosclerosis progression or regression. Ann Intern Med. 1994 Sep 01; 121(5):348-54.
Limitations of angiography for analyzing coronary atherosclerosis progression or regression.
Ormiston JA, Mahmud E, Turco MA, Popma JJ, Weissman N, Cannon LA, Mann T, Lucca MJ, Lim ST, Hall JJ, McClean D, Dobies D, Mandinov L, Baim DS
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study. JACC Cardiovasc Interv. 2008 Apr; 1(2):150-60.
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study.
Deeb GM, Chetcuti SJ, Yakubov SJ, Patel HJ, Grossman PM, Kleiman NS, Heiser J, Merhi W, Zorn GL, Tadros PN, Petrossian G, Robinson N, Mumtaz M, Gleason TG, Huang J, Conte JV, Popma JJ, Reardon MJ
Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2018 04; 105(4):1129-1136.
Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement.
Methodist DeBakey cardiovascular journal
Clinical studies assessing transcatheter aortic valve replacement. Methodist Debakey Cardiovasc J. 2012 Apr-Jun; 8(2):13-8.
Clinical studies assessing transcatheter aortic valve replacement.
Drudi LM, Ades M, Turkdogan S, Huynh C, Lauck S, Webb JG, Piazza N, Martucci G, Langlois Y, Perrault LP, Asgar AW, Labinaz M, Lamy A, Noiseux N, Peterson MD, Arora RC, Lindman BR, Bendayan M, Mancini R, Trnkus A, Kim DH, Popma JJ, Afilalo J
Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement. JAMA Cardiol. 2018 03 01; 3(3):191-197.
Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement.
Forrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR
Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC Cardiovasc Interv. 2018 01 22; 11(2):160-168.
Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap.
Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development. Heart. 2012 Nov; 98 Suppl 4:iv37-43.
Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development.
Kramps JA, van Maanen K, Mars MH, Popma JK, van Rijn PA
Validation of a commercial ELISA for the detection of bluetongue virus (BTV)-specific antibodies in individual milk samples of Dutch dairy cows. Vet Microbiol. 2008 Jul 27; 130(1-2):80-7.
Validation of a commercial ELISA for the detection of bluetongue virus (BTV)-specific antibodies in individual milk samples of Dutch dairy cows.
Management of patients after coronary angioplasty. Am Fam Physician. 1990 Jan; 41(1):121-9.
Management of patients after coronary angioplasty.
Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Wong SC, Leon MB
Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol. 1995 Sep; 26(3):720-4.
Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.
Henson KD, Leon MB, Popma JJ, Pichard AD, Satler LF, Eigler N, Litvack F, Rothbaum D, Goldenberg T, Kent KM
Treatment of refractory coronary occlusions with a new excimer laser catheter: preliminary clinical observations. Coron Artery Dis. 1993 Nov; 4(11):1001-6.
Treatment of refractory coronary occlusions with a new excimer laser catheter: preliminary clinical observations.
Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Yeh RW
National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. EuroIntervention. 2018 04 06; 13(18):e2152-e2159.
National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock.
Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P
Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 1997 Jun 12; 336(24):1697-703.
Catheter-based radiotherapy to inhibit restenosis after coronary stenting.
Popma JJ, Lansky AJ, Yeh W, Kennard ED, Keller MB, Merritt AJ, DeFalco RA, Desai A, Pacera JH, Schnabel JF, Niedermeyer V, Baim DS, Detre KM
Reliability of the quantitative angiographic measurements in the New Approaches to Coronary Intervention (NACI) registry: a comparison of clinical site and repeated angiographic core laboratory readings. Am J Cardiol. 1997 Nov 20; 80(10A):19K-25K.
Reliability of the quantitative angiographic measurements in the New Approaches to Coronary Intervention (NACI) registry: a comparison of clinical site and repeated angiographic core laboratory readings.
Abizaid A, Mintz GS, Abizaid AS, Satler LF, Popma JJ, Pichard AD, Mehran R, Kent KM, Leon MB
[Clinical application of intracoronary ultrasound]. Arq Bras Cardiol. 1997 Oct; 69(4):263-5.
[Clinical application of intracoronary ultrasound].
Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation. 2000 Feb 01; 101(4):360-5.
Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial.
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001 Jan 15; 87(2):157-62.
Bashore TM, Bates ER, Kern MJ, Berger PB, Laskey WK, Clark DA, O'Laughlin MP, Cusma JT, Oesterle S, Dehmer GJ, Popma JJ
American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards: summary of a report of the American College of Cardiology Task Force on clinical expert consensus documents. Catheter Cardiovasc Interv. 2001 Jun; 53(2):281-6.
American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards: summary of a report of the American College of Cardiology Task Force on clinical expert consensus documents.
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001 Jun 15; 37(8):2215-39.
ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).
Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 2001 Oct 23; 104(17):2007-11.
Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
Popma JJ, Dehmer GJ, Walker BS, Simon TR, Smitherman TC
Analysis of thallium-201 single-photon emission computed tomography after intravenous dipyridamole using different quantitative measures of coronary stenosis severity and receiver operator characteristic curves. Am Heart J. 1992 Jul; 124(1):65-74.
Analysis of thallium-201 single-photon emission computed tomography after intravenous dipyridamole using different quantitative measures of coronary stenosis severity and receiver operator characteristic curves.
Adjuncts to thrombolysis for myocardial reperfusion. Ann Intern Med. 1991 Jul 01; 115(1):34-44.
Adjuncts to thrombolysis for myocardial reperfusion.
Shah PB, Cutlip DE, Popma JJ, Kuntz RE, Ho KK
Incidence and predictors of late total occlusion following coronary stenting. Catheter Cardiovasc Interv. 2003 Nov; 60(3):344-51.
Incidence and predictors of late total occlusion following coronary stenting.
Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004 Feb 10; 109(5):634-40.
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS
Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol. 2005 Jan 15; 95(2):173-7.
Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.
Holmes DR, Wondrow M, Stueve R, Grill D, Kasson RT, Popma J, Laskey W
Variability of radiation output dynamic range in modern cardiac catheterization imaging systems. Cathet Cardiovasc Diagn. 1998 Aug; 44(4):443-8.
Variability of radiation output dynamic range in modern cardiac catheterization imaging systems.
Mintz GS, Potkin BN, Keren G, Satler LF, Pichard AD, Kent KM, Popma JJ, Leon MB
Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease. Circulation. 1992 Nov; 86(5):1383-93.
Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease.
Wong SC, Popma JJ, Kent KM, Pichard AD, Satler LF, Mintz GS, Leon MB
Clinical experience with stent implantation in the treatment of saphenous vein graft lesions. J Interv Cardiol. 1994 Dec; 7(6):565-73.
Clinical experience with stent implantation in the treatment of saphenous vein graft lesions.
Stent versus Stent Equivalency Trials. Textbook of Coronary Stenting. Leon MB, Stone GW (Editors). 2005.
Cox NR, Prpic R, Kuntz RE, Fitzpatrick M, Giri S, Kaya U, Baim DS, Popma JJ
Angiographic indicators for the use of distal protection devices in saphenous vein graft interventions. J Am Coll Cardiol. 2002; 39(5):8A.
Angiographic indicators for the use of distal protection devices in saphenous vein graft interventions
A Critical Appraisal of Decision Analytic Models to Evaluate the Cost-Effectiveness of Stenting. J Invasive Cardiol. 1997; 9(Suppl A):3A-6A.
A Critical Appraisal of Decision Analytic Models to Evaluate the Cost-Effectiveness of Stenting
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 2006 Aug 22; 114(8):798-806.
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.
Atlas of Interventional Cardiology. 1992.
Antithrombotic therapy in patients undergoing coronary angioplasty. Chest 1998 Nov;114(5 Suppl):728S-741S. 1998; 114(5 Suppl):728S-741S.
In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med. 1987 Sep 24; 317(13):805-9.
In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries.
Mehran R, Mintz GS, Satler LF, Pichard AD, Kent KM, Bucher TA, Popma JJ, Leon MB
Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. Circulation. 1997 Oct 07; 96(7):2183-9.
Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone.
Hong MK, Popma JJ, Baim DS, Yeh W, Detre KM, Leon MB
Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 1997 Nov 20; 80(10A):40K-49K.
Frequency and predictors of major in-hospital ischemic complications after planned and unplanned new-device angioplasty from the New Approaches to Coronary Intervention (NACI) registry.
Hicks RJ, Melon P, Kalff V, Wolfe E, Dick RJ, Popma JJ, Topol E, Schwaiger M
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Metabolic imaging by positron emission tomography early after myocardial infarction as a predictor of recovery of myocardial function after reperfusion. J Nucl Cardiol. 1994 Mar-Apr; 1(2 Pt 1):124-37.
Metabolic imaging by positron emission tomography early after myocardial infarction as a predictor of recovery of myocardial function after reperfusion.
Lansky AJ, Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Baim DS, Kuntz RE, Simonton C, Bersin RM, Hinohara T, Fitzgerald PJ, Leon MB
Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study. J Am Coll Cardiol. 1998 Aug; 32(2):329-37.
Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the Optimal Atherectomy Restenosis Study.
Abizaid A, Mintz GS, Abizaid AS, Pichard AD, Kent KM, Satler LF, Popma JJ, Bhargava B, Leon MB
Role of intravascular ultrasound and Doppler flow studies in coronary interventions. Indian Heart J. 1998 Oct; 50 Suppl 1:99-103.
Role of intravascular ultrasound and Doppler flow studies in coronary interventions.
Grube E, Webb J, Prpic R, Giri S, Rao R, Kuntz RE, Beck L, Chan S, Lanina A, Firer L, Popma JJ
Clinical safety and efficacy of the PercuSurge Guardwire in the Saphenous Vein Graft Angioplasty Free of Emboli (SAFE) Study. J Am Coll Cardiol. 2000; 35(2):41A.
Clinical safety and efficacy of the PercuSurge Guardwire in the Saphenous Vein Graft Angioplasty Free of Emboli (SAFE) Study
Lansky AJ, Roubin GS, O'Shaughnessy CD, Moore PB, Dean LS, Raizner AE, Safian RD, Zidar JP, Kerr JL, Popma JJ, Mehran R, Kuntz RE, Leon MB
Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation. 2000 Sep 19; 102(12):1364-8.
Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses.
Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001 Jan 16; 103(2):192-5.
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
Kwok OH, Prpic R, Kinlay S, Giri S, Popma J, Fischell T
Quantitative angiographic outcome after intracoronary pullback atherectomy. Am J Cardiol. 2001 May 01; 87(9):1108-10, A9.
Quantitative angiographic outcome after intracoronary pullback atherectomy.
Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E
Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheter Cardiovasc Interv. 2002 Oct; 57(2):125-34.
Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention.
Savage MP, Fishman DL, Kuntz RE, Laskey W, Bass TA, Teirstein PS, Popma JJ, Kuntz RE
Interprocedural interval as a risk factor for recurrent stenosis after treatment of in-stent restenosis: Differential response with and without brachytherapy. J Am Coll Cardiol. 2002; 39(5):65A.
Interprocedural interval as a risk factor for recurrent stenosis after treatment of in-stent restenosis: Differential response with and without brachytherapy
Wong SC, Kent KM, Mintz GS, Pichard AD, Satler LF, Garcia J, Hong MK, Popma JJ, Leon MB
Percutaneous transcatheter repair of a coronary aneurysm using a composite autologous cephalic vein-coated Palmaz-Schatz biliary stent. Am J Cardiol. 1995 Nov 01; 76(12):990-1.
Percutaneous transcatheter repair of a coronary aneurysm using a composite autologous cephalic vein-coated Palmaz-Schatz biliary stent.